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1. Abbreviations 
AP-1 activated protein 1 
APC antigen presenting cell 
Cbl casitas B-lineage lymphoma 
Cbp Csk binding protein 
CD cluster of differentiation 
Csk C-terminal Src kinase 
ERK extracellular signal regulated kinase 
GAP GTPase activating protein 
GEF guanine nucleotide exchange factor 
Grb2 growth factor receptor bound protein 2 
IKK IțB kinase 
IL-2 interleukin 2 
IS immunological synapse
ITAM immunoreceptor tyrosine based activation motif 
kd knockdown
LAT linker for activation of T cells 
Lck lymphocyte-specific protein-tyrosine kinase 
LIME Lck interacting membrane protein 
MAPK mitogen activated protein kinase 
MHC major histocompatibility complex 
NFAT nuclear factor of activated T cells 
NFțB nuclear factor țB
PAG phosphoprotein associated with glycosphingolipid enriched microdomains 
PI3K phosphatidylinositol 3 kinase 
PKC protein kinase C 
PLC phospholipase C 
PKR protein kinase RNA 
Ras rat sarcoma 
SFK Src family kinase 
SH Src homology 
SHP-1 SH2 domain containing protein tyrosine phosphatase 1 
SLP-76 SH2 domain containing leukocyte protein of 76 kD 
SOS son of sevenless 
Src sarcoma (from Rous sarcoma) 
TCR T cell receptor 
ZAP-70 ȗ -chain-associated protein of 70 kD 
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9Abstract
We have targeted Lck with siRNA-mediated RNA interference and investigated signaling 
properties in T cells with Lck knockdown. Proximal signaling was reduced in Lck-kd cells, 
as determined by overall tyrosine phosphorylation, CD3ȗ phosphorylation and Ca2+
mobilization. Despite this, NFAT-AP-1 activation and IL-2 secretion was increased (Paper 
I). We found that Grb2-SOS1 was recruited to hypophosphorylated CD3-zeta in these cells, 
leading to sustained Ras-Raf-1-ERK1/2 activation (Paper II). Furthermore, endocytosed 
TCR/CD3-containing vesicles were not targeted to lysosomes, and CD3-zeta levels 
remained elevated in Lck-kd cells (Paper III). This indicates that prolonged survival of 
internalized TCR/CD3-complexes may lead to sustained signaling through the Grb2-SOS1-
Ras-ERK pathway. If allowed to operate in the absence of negative feedback mediated by 
SHP-1 (Paper I), Ras-GAP (Paper II), and c-Cbl (Paper III) Lck-kd may thus result in 
hyperresponsive signaling in T cells with low Lck levels.
We have also investigated the involvement of G proteins in TCR-mediated immune 
responses, and the possible interplay between GĮq and Lck (Paper IV). TCR engagement 
activated GĮq and GĮs but not GĮi-2. Targeting of GĮs, GĮi-2 and GĮq using siRNA-
mediated knockdown demonstrated a specific role of GĮq in T cell activation with an 
increase in the transcriptional activation of NFAT-AP1, despite reduced proximal signaling. 
The same was found in primary T cells from GĮq deficient mice which displayed 
hyperproduction of IL-2, but a reduced ability to activate proximal signaling events. 
3. Introduction 
3.1. The immune system 
The human body is under constant attack from infectious agents such as viruses, bacteria, 
fungi, protozoa and parasites, and many mechanisms have evolved to protect us against 
these threats. Very few infectious agents can penetrate the barrier of intact skin, but the 
epithelia and mucus membranes of the nasopharynx, lungs, gastrointestinal and urogenital 
tracts are more vulnerable to entry. Microorganisms come in many different forms, and they 
continually change structure and strategy to breach or evade our first line defences. When 
infectious agents gain access to the body, they may cause disease, which can be fatal if left 
unchecked. A flexible immune response is therefore required to deal with the large variety 
of microorganisms. Recognition of pathogens is essential for the immune system, and 
especially separation from self and harmless material. The two main categories of pathogen 
recognition are the innate (non-adaptive) and adaptive immune responses. The former 
employs a fixed set of  mechanisms which have co-evolved with emerging microbes, and 
detect classical patterns in foreign material, such as bacterial carbohydrates 
(lipopolysaccharide), nucleic acids (bacterial or viral DNA or RNA) and peptidoglycans. In 
the adaptive immune response, T and B lymphocytes are responsible for specific immune 
recognition. T cells regulate, direct or execute immune effector functions, and are the 
subject of the next chapter. B cells produce antibodies. The hallmark of adaptive immunity 
is a custom tailored response to each microorganism. The response is therefore slower in 
onset but more potent than innate immunity. The adaptability of the system is achieved by 
somatic mutations and irreversible recombination of antigen receptor gene segments. These 
mechanisms allow a small number of genes to generate a vast number of different antigen 
receptors, which are then expressed on individual lymphocytes. Lymphocytes with self-
reacting receptors are eliminated, and the body thereby generates a receptor repertoire for 
essentially all antigens that are non-self. Triggering of a particular receptor gives rise to 
clonal selection and proliferation of the lymphocyte, and because the gene rearrangements 
have lead to an irreversible change in the DNA of each cell, all of the progeny will inherit 
genes encoding the same receptor specificity. This includes the T and B memory cells which 
are keys to long-lived specific immunity. 
3.2. T cells 
The main classes of T cells are the CD4+ helper (Th), CD8+ cytotoxic (Tc) and FOXP3+ 
regulatory (Treg) cells. All T cells develop from lymphoid bone marrow progenitor cells 
and are educated in the thymus. Naïve T cells migrate through lymph nodes, spleen and 
other secondary lymphoid organs, ready to be activated by the interaction with professional 
antigen presenting cells (APCs), such as macrophages, B cells and dendritic cells. CD4+ T 
cells regulate and direct cytotoxic (Th1) or humoral (Th2) immune responses depending on 
the type of infection encountered. The former is typically mounted against virus infections 
and cancer cells, whereas the latter targets bacterial and protozoan infections. The Th1 and 
Th2 responses are characterized mainly by the profile of cytokines produced, which in turn 
activate specific subsets of immune cells. The Th1 response involves IFNȖ, TNF and IL-2, 
and triggers cell-mediated inflammatory reactions executed by NK cells, macrophages and 
Tc cells. Tc cells eliminate virus infected cells and cancer cells through direct intervention 
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after recognition of foreign antigen presented on MHC class I molecules. The Th2 response 
involves IL-4, IL-5, IL-10 and IL-13, and activate B cells. B cells produce and secrete 
antibody molecules, which bind infectious material and mark it for destruction. Tregs 
suppress immune responses after an infection has been purged, and thereby maintain 
immune system homeostasis and tolerance to self. Aberrant or disturbed activation of T 
cells may lead to autoimmune diseases or immunodeficiency.  
3.3. T cell receptor signaling 
The T cell receptor (TCR) complex 
consists of the heterodimeric Įȕ
chains and a  set of six polypeptides, 
the CD3 chains, designated Ȗİ ȗȗ įİ
(Fig.1). APCs continously process 
exogenous peptides and present them 
on MHC class II molecules. The TCR 
interacts with peptide-loaded MHC 
class II molecules but will only be 
engaged with sufficient strength if 
there are matching antigen epitopes 
present (Reviewed in Kuhns et al. 
2006, and Rudolph et al., 2006). Many 
factors are involved in proper 
activation of T cells. The strength and 
duration of the TCR-MHC class II engagement is important, but also the presence of a co-
stimulatory signal mediated through CD28. CD28 interaction with B7 proteins on APCs 
ensures that the TCR is engaged by professional immune cells, and not  accidentally by 
other cells or by soluble antigen. Absence of a secondary CD28 signal will lead to T cell 
anergy, a state characterized by a lack of T cell responsiveness to otherwise effective 
antigens. Anergy has emerged as a fundamental mechanism for preventing autoimmune 
responses to self-antigens. 
Figure 1. The TCR/CD3-complex 
The TCR is located in specialized plasma membrane microdomains, termed lipid rafts. 
Lipid rafts consist of cholesterol and sphingolipid-enriched platforms which segregate 
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various signaling molecules, and are postulated to function in signaling and membrane 
trafficking (Ilangumaran et al., 2000; Marmor and Julius, 2001; Harder, 2001; Horejsi, 
2003). The immunological synapse is a term used to denote the complex array of protein-
protein interactions which arises between a T cell and an APC (Monks et al. 1998; Grakoui 
et al., 1999; Reviewed in Dustin et al., 2005). The formation and organization of an 
immunological synapse is constituted by the coalescence of lipid rafts and recruitment of 
signaling proteins, the binding of integrins and adhesion molecules, as well as the TCR-
MHC class II and CD28-B7 contacts. Altogether, this platform relays coordinated signals 
from the exterior to the interior of the T cell. Intracellular TCR signaling will be elaborated 
in the following chapters. Briefly summarized, Lck becomes activated upon TCR 
engagement, and phosphorylates the intracellular portions of the TCR/CD3-complex. ZAP-
70 binds and phosphorylates LAT, to which many adaptor and effector proteins are 
recruited. This culminates with the mobilization of intracellular Ca2+ and activation of PKC 
and Ras. In turn, transcription factors translocate to the nucleus of the T cell. Activated T 
cells secrete a plethora of cytokines which lead to proliferation and differentiation of 
immune cells. 
3.4. Lck and Src family kinases 
The most membrane proximal event to take place after engagement of the TCR is the 
activation of Lck (Lymphocyte specific tyrosine kinase). Lck is a 509 amino acids long, 56-
kD nonreceptor protein-tyrosine kinase of the Src oncogene family. The Src family of 
kinases (SFKs) also contain the members Src, Yes, Fyn, Lyn, Hck, Fgr and Blk, but only 
Lck, Fyn and Yes are expressed in T cells (Kitamura et al., 1982; Marth et al., 1985; 
Voronova and Sefton, 1986; Semba et al., 1986; Cooke and Perlmutter 1989; Olszowy et al., 
1995). The SFKs share many structural and functional features of Lck, and since Lck is is 
the main topic of this thesis, it will serve as a model example of a Src kinase in the 
following presentation. 
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3.4.1 Structure of Lck 
Lck is composed of SH3, SH2 and SH1 domains 
arranged sequentially from the N-terminus to the C-
terminus (see Fig. 2). The SH3 domain is 57 residues 
long and interact with proline rich regions with a 
central PXXP motif (Cohen et al., 1995). The SH2 
domain is 91 residues long and interacts with certain 
phospho-tyrosines (the Src SH2 domain prefer the 
sequence pYEEI/L) (Cohen et al., 1995; Pawson, 
1995). The SH1 domain is a 250 residue-long tyrosine kinase. Although Fyn and Lck both 
have SH2 and SH3 domains, the binding specificities of these domains are significantly 
different, and confer unique functions to these SFKs in T cell signaling (Lin et al., 2000; and 
reviewed in Zamoyska et al., 2003). Lck functions primarily as a tyrosine kinase, but both 
the SH2 (Straus et al., 1996; Lewis et al., 1997) and the SH3 domain (Denny et al., 1999) 
have been shown to be important for signaling in T cells. 
Figure 2. Lck 
Lck is anchored to the plasma membrane through lipid modifications (Marchildon et al., 
1984; Marth et al., 1985, Voronova and Sefton, 1986). The N-terminal residues G2 and 
C3/5 are myristoylated and palmitoylated respectively (Marchildon et al., 1984; Johnson et 
al., 1994, Paige et al., 1993; Koegl et al., 1994; Yurchak et al., 1995). Fyn also contains 
lipid anchors, but the localizations of Lck and Fyn are non-overlapping in T cells, 
suggesting spatial organization by other mechanisms (Ley et al., 1994; Lin et al., 2000; 
Filipp et al., 2003; Filipp et al. 2004). Lck interacts with two cysteines within an CXCP 
motif in the intracellular domains of CD4 and CD8 through a unique SH4 domain in a zinc-
dependent manner (Veillette et al., 1988; Rudd, et al., 1988; Rudd et al., 1989; Luo and 
Sefton, 1990; Turner et al., 1990; Kim et al., 2003). Approximately 50% of Lck in T cells 
interact with CD4 in this way (Veillette et al., 1988), and since CD4 is normally excluded 
from lipid rafts, so is Lck. In fact, up to 95% of Lck to resides in soluble membrane 
fractions, whereas more than 98% of Fyn concentrates within lipid rafts, some of which 
associates with the TCR/CD3-complex (Samelson et al., 1990; Timson Gauen et al., 1992; 
Filipp et al., 2003). There is some controversy in the field regarding Lck and lipid raft 
translocation. It has been reported that a large fraction of Lck resides in lipid rafts even in 
resting cells, and that CD28 but not CD4 stimulation results in more Lck recruitment into 
rafts (Tavano et al., 2004). 
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3.4.2. Lck and Fyn in T cell development 
Lck is primarily expressed in T cells where it serves many functions, both in signaling and T 
cell ontogeny. TCR signaling affects the selection and survival of T cells at every stage of 
development (Shortman and Wu, 1996, Sebzda et al., 1999; Kruisbeek et al., 2000). Lck 
knockout mice display thymic atrophy and diminished double positive (CD4+CD8+) 
thymocytes (Molina et al., 1992). Mature, single positive thymocytes could not be detected 
in these animals and peripheral T cell counts were very low Similar findings have been 
reported with transgenic mice expressing a dominant-negative version of Lck (Levin et al., 
1993). This underscores an important role of Lck in T cell development for which Fyn can 
not compensate. Thymocytes from Fyn-deficient mice undergo normal maturation (Stein et 
al., 1992; Appleby et al., 1992). However, Fyn is not completely dispensable since knockout 
of both Lck and Fyn leads to a complete arrest in T cell development at the double negative 
(CD4-CD8-) thymocyte stage (van Oers et al., 1996a; Groves et al., 1996). 
3.4.3. Regulation of Lck by phosphorylation and dephosphorylation 
Lck is phosphorylated on two main residues, Y394 (Marth et al., 1988; Veillette et al., 
1989a; Veillette et al., 1989b; Lou and Sefton, 1990; Abraham and Veillette, 1990) and 
Y505 (Courtneidge, 1985; Cooper et al., 1986; Cooper and King, 1986; Amrein and Sefton, 
1988;  MacAuley and Cooper, 1989). The former is an autophosphorylation site which leads 
to 2-4 fold increased tyrosine kinase activity. The latter is phosphorylated by C-terminal Src 
Kinase (Csk) which inhibits Lck (Okada and Nakagawa 1989; Thomas et al., 1991; Nada et 
al., 1991; Okada et al., 1991; Bergman et al., 1992). Phosphorylated Y505 interacts with the 
intrinsic SH2 domain of Lck, thus folding the protein onto itself. This inhibits the kinase 
domain indirectly by inducing conformational changes in the catalytic site (Yamaguchi and 
Hendrickson, 1996; Sischeri et al., 1997; Xu et al., 1997; Xu et al., 1999). pY394 is 
dephosphorylated primarily by the PTPases SHP-1, CD45 and LYP (Wu et al., 2006), 
wheras pY505 is dephosphorylated mainly by CD45. SHP-1 is a central negative regulator 
of T cell signaling and is presented in chapter 3.7.2. CD45 is expressed in all nucleated 
hematopoietic cells, but not in other cell types (Mustelin et al., 1989; Mustelin et al., 1990; 
Mustelin et al., 1992). In CD45-deficient lymphocytes both Lck and Fyn are 
hyperphosphorylated on Y505 and Y528 respectively, and these cells show diminished 
responses to antigen stimulation (Pingel and Thomas 1989; Ostergaard et al., 1989; 
Koretzky et al., 1990; Kishihara et al., 1993; Stone et al., 1997). Membrane targeting or 
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overexpression of Csk is sufficient to inhibit TCR induced phosphorylation and IL-2 
production through phosphorylation of Y505 (Chow et al., 1993). In contrast, deletion or 
mutation of Y505 in Lck results in a constitutively active enzyme (Marth et al., 1988; 
Abraham et al., 1991; Chow et al., 1993). Dephosphorylation of pY505 is therefore thought 
to be a critical positive regulator of Lck and Fyn in T cells. Lck is also phosphorylated on 
S59 (Winkler et al., 1993), and this regulates the specificity of the SH2 domain (Joung et al., 
1995). Weak TCR ligands may trigger a negative feedback loop dependent on the 
recruitment of SHP-1 to Lck. This is prevented when stronger ligands bind though ERK-
dependent phosphorylation of S59 in Lck (Stefanova et al., 2003). Phosphorylation of Y192 
within the SH2 domain of Lck disrupts SH2 binding, thereby negatively regulating its 
participation in T cell antigen receptor signaling (Couture et al., 1996). 
3.4.4. Activation and function of Lck 
The TCR/CD3-complex lacks enzymatic activity and is therefore dependent on external 
kinase activity for signal transmission. Lck is considered to be the principal mediator of this 
function (Veillette et al., 1989a; Veillette et al., 1989b; Veillette et al., 1989c; Barber et al., 
1989; Abraham et al., 1991; Luo and Sefton, 1992). However, the exact nature of how Lck 
becomes activated after engagement of the TCR is still elusive. Several mechanisms have 
been proposed: Release from tonic inhibition bt Csk, dephosphorylation of the inhibitory 
pY505 by CD45, clustering within the immunological synapse and juxtaposition of Lck 
with the TCR/CD3-complex through CD4-Lck interaction with MHC class II molecules. 
Other forms of SFK activation have also been described. For example, it has been shown 
that engagement of the SH3 domain of Lck by a proline-rich sequence in CD28 increases 
the phosphotransferase activity of Lck (Holdorf et al., 1999). Furthermore, engagement of 
the IL-2 receptor increases the activity of bound Lck (Horak et al., 1991), although IL-2 
signaling is not dependent on Lck (Karnitz et al., 1992). In fact, T cells from Lck -/- mice 
exibit enhanced proliferative responses to IL-2 stimulation (Molina et al., 1992). Src 
interaction with small G proteins is discussed in chapter 3.8., and examined in more detail in 
Paper IV. The kinetics and discrete regulation of Y394 and Y505 dephosphorylation by 
CD45 is not fully elucidated, and it is likely that CD45 has a role as both positive and 
negative regulator of T cell signaling, which is underscored by recent data (McNeill 2007). 
It has also been reported that CD4-Lck clusters outside the immunological synapse, away 
from the TCR-CD3 complex (Ehrlich et al., 2002). Furthermore, stimulation with anti-CD3İ
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antibodies (OKT3) is sufficient to trigger robust Lck activation in Jurkat and primary T 
cells, but the link between CD3İ engagement and Lck activation is still unknown. 
Although different mechanisms of activation exist, it is evident that Lck becomes activated 
upon TCR engagement. The main substrates for Lck are the CD3-chains of the TCR-
complex (Barber et al. 1989), and several lines of evidence suggest a pivotal role for Lck in 
signal transmission through the TCR. Pharmacological inhibition of Lck and Fyn with PP2, 
or new specific Lck inhibitors, abolish anti-CD3-induced T cell signaling (Hanke et al., 
1996; Rapecki et al., 2002). The Jurkat cell line JCaM1, which is deficient in Lck, does not 
respond to anti-CD3 engagement, and reconstitution of these cells with Lck restores T cell 
signaling (Goldsmith and Weiss, 1987; Straus and Weiss, 1992). Fyn may also 
phosphorylate the TCR/CD3-complex, but overexpression of Fyn in JCaM1 cells only leads 
to a partial recovery (Denny et al., 2000). On the other hand, it has been shown that Syk is 
activated independently of Lck upon CD3-stimulation (Couture et al., 1994; Chu et al., 
1996), and reconstitution of JCaM1 cells with Syk, but not ZAP-70, could also restore 
signaling to ERK (Williams et al., 1997).  Knockout mice have been generated for both Lck 
and Fyn, and data from these animals indicate that Lck is important, but not indispensible 
for the TCR/CD3 signaling pathway. The proliferative response to anti-CD3 or TCRĮȕ
crosslinking was substantially reduced in Lck -/- T cells, but was still higher than in 
unstimulated cells (Molina et al., 1992). Phosphorylation of CD3ȗ and ZAP-70 was virtually 
absent in murine Lck -/- thymocytes, but several phosphoproteins were induced, although to 
a lower degree and with slower kinetics than in wild-type cells (van Oers et al., 1996b). 
TCR engagement resulted in CD69 expression in Lck deficient mice, albeit to a 
substantially lower level than in control animals. Furthermore, peripheral T cells from Lck -
/- mice showed normal responsiveness to allostimulation (allo-MHC antigens), suggesting 
that Lck is not required for this T cell effector function (Yamada et al., 1997). A major 
problem with Lck knockout animals is that compensatory mechanisms may have developed, 
and that the few T cells that do mature may represent a population that has adapted to the 
loss of Lck. Lck–/– mice may therefore not be the best model to investigate all aspects of Lck 
signaling in vivo, and conditional transgenic mice (Lck1ind) that express Lck by a T cell-
specific tet-inducible mechanism have been developed. This model has reveled a central role 
for Lck in the differentiation of CD4 and CD8  thymocytes, but no detectable change in T 
cell numbers in peripheral lymphoid organs was observed even 9 weeks after loss of Lck 
(Legname et al., 2000; Tewari et al., 2006). Interestingly, it has been shown that the absence 
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of Lck actually increased the long-term survival of naïve T cells (Seddon et al., 2000), and 
that Lck expression was not essential for responses of memory CD8+ T cells to secondary 
antigen stimulation in vivo or in vitro (Tewari et al., 2006). One report has used mice 
expressing a Lck transgene in the thymus to overcome the developmental block associated
with the Lck–/– background (Trobridge and Levin 2001). It was shown that primary Lck–/– T 
cells from these animals had an impaired Ca2+ mobilization and defective proliferation.
However, the authors also showed that T cells expressing an excess of a catalytically 
inactive Lck were capable of inducing Ca2+-fluxes, suggesting that Lck kinase activity is not 
essential in T cell activation. TCR signaling in Lck1ind mice with or without the Fyn -/-
background has recently been investigated (Lovatt et al., 2006). In this system, T cells with 
low levels or complete absence of Lck was compared to wild-type cells. It was shown that 
Lck controls the threshold of T cell activation by specifically activating the CD3ȗ-ZAP-70-
LAT-PLCȖ1-pathway, leading to Ca2+ dependent induction of IL-2 synthesis. Surprisingly, 
crosslinking CD4 with the TCR enhanced signal transduction even in the absence of Lck, 
resulting in Ca2+ flux and phosphorylation of some LAT residues in Lck-deficient T cells. 
This occured without  ZAP-70 or PLCȖ1 phosphorylation. Furthermore, the activation of
MEK and ERK was surprisingly high in Lck-low or Lck-deficient mice, although reduced 
compared to wild type animals. Fyn was shown to be responsible for these effects, and the 
authors concluded that Lck and Fyn target the ERK1/2-pathway through distinct Ras 
activators. Interestingly, when intracellular IL-2 was visualized, a significant proportion of
Lck-deficient cells were found to produce IL-2 even though secretion was reduced. This 
indicates that signals received in the absence of Lck are sufficient to open the IL-2 locus but 
insufficient to induce normal levels of IL-2 secretion. Work included in this thesis 
investigate further how low levels of Lck may result in T cell signaling (Paper I and II). 
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3.4.5 Summary of Lck interaction partners and/or substrates 
Table 1. Lck interaction partners and/or substrates 
Protein Reference
Cbl I Rao et al., 2002, Hawash et al., 2002 
CD28 I Holdorf et al., 1999 
CD3ȗ/İ/Ȗ/į S Barber et al., 1989, Straus and Weiss 1992, van Oers 1996b 
Ezrin S Autero et al., 2003 
Fyn S Filipp et al., 2003 
IL-2 receptor I/S Hatakeyama et al., 1991, Delespine-Carmagnat 1999 
Itk S Heyeck et al., 1997 
LAT S Jiang and Cheng, 2007 
LIME I/S Brdickova et al., 2003, Hur et al., 2003 
PKCį/ș S Konishi et al., 2001, Liu et al., 2000 
PLCȖ1 S Liao et al., 1993 
Ras-GAP S/I Amrein et al., 1992, Amrein et al., 1994 
Shc S/I Walk et al., 1998, Fukushima et al., 2005 
SHP-1 S/I Lorenz et al., 1994 
Unc119 I Gorska et al., 2004 
Vav1 S Gulbins et al., 1993 
ZAP-70 S/I Duplay et al., 1994, Pelosi et al., 1999 
I = Interaction partner; S=Substrate 
3.4.6 Fyn 
Fyn has been shown to be important for signal transduction in T cells (Cooke et al., 1991; 
Tsygankov et al., 1992). Peripheral T cells from Fyn -/- animals display relatively normal 
proliferative responses, but have blunted Ca2+ mobilization and IL-2 production (Stein et al., 
1992; Appleby et al., 1992). Although Fyn plays a role in T cell signaling, it does not have 
the same impact as Lck, since overexpression of Fyn can not fully substitute for the loss of 
Lck (Denny et al., 2000). It has been shown that Fyn requires Lck recruitment to lipid rafts 
for its activation, and Fyn thus appears to be dependent on and function subsequently to Lck 
upon TCR engagement (Filipp et al., 2003; Filipp et al., 2004). Some lines of evidence have 
suggested that one of the roles of Fyn is to dampen T-cell responses, while Lck acts to 
amplify them (Lovatt et al., 2006; Filby et al., 2007). Fyn provides incomplete signals, such 
as those delivered by antagonistic ligands (Utting et al., 1998), and Fyn interacts specifically 
with some negative regulators of T-cell activation, such as c-Cbl (Tsygankov et al., 1996; 
see chapter 3.7.4.) and Cbp/PAG (Yasuda et al., 2002). Cbp/PAG is a transmembrane 
protein which binds Csk when phosphorylated (Brdicka et al., 2000; Kawabuchi et al., 
2000). TCR stimulation leads to transient dephosphorylation of Cbp/PAG, probably in a 
CD45-dependent manner, therby releasing Csk from its plasma membrane anchor, and thus 
facilitating T cell activation (Torgersen et al., 2001; Davidson et al., 2003). Fyn-mediated 
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rephosphorylation of Cbp/PAG leads to the recruitment of Csk, and thereby constitutes a 
negative feedback mechanism. The function of Cbp/PAG is, however, still under 
investigation. In contrast to Csk null mutation, which leads to embryonic lethality (Imaoto 
and Soriano, 1993; Nada et al., 1993), Cbp/PAG-deficient mice appear normal (Dobenecker 
et al., 2005; Xu et al., 2005). Dobenecker et al. reported that Csk was still recruited to lipid 
rafts in these animals, indicating that other Csk adaptors compensate for the loss of 
Cbp/PAG. On the other hand, Xu. et al. reported that raft localization of Csk was greatly 
reduced, but that this did not lead to any detectable functional defects in T cell signaling. A 
recent report showed that siRNA-mediated knockdown of Cbp/PAG enhanced SFK and Ras 
activation (Smida et al., 2007). It has also been shown that Fyn-dependent phosphorylation 
of Cbp/PAG is involved in the induction of anergy (Davidson et al., 2007). Other interaction 
partners of Fyn in T cell signaling are SAP/SLAM (Chan et al., 2003; Latour et al., 2003; 
Davidson et al., 2004), Fyb (Da Silva et al., 1997) and the focal adhesion kinase family 
(Kanazawa et al., 1996). Phosphorylation of Pyk2 links Fyn to cytoskeletal organization, 
cell spreading and migration (Qian et al., 1997) 
3.4.7. Lck and human pathophysiology 
Aberrant expression or regulation of Lck has been associated with several diseases. Some 
patients with systemic lupus erythematosus (SLE) have T cells with decreased levels of Lck 
due to increased ubiquitin-mediated degradation. The specific Lck activity, however, was 
increased, and the T cells displayed augmented apoptosis and lipid raft abnormalities 
(Matache et al., 1999; Matache et al., 2001; Jury et al., 2003).
Patients with common variable immunodeficiency (CVID) or severe combined immuno 
deficiency (SCID) have been reported to have reduced Lck levels (Goldman et al., 1998; 
Sawabe et al., 2001). In both patients it was shown that the lck transcript lacked the entire 
exon 7 resulting in reduced or almost complete loss of Lck expression. Interestingly, JCaM1 
cells exibit the exactly same defect, but the responsible mutation is yet to be found. 
Surprisingly, anti-CD3-induced tyrosine phosphorylation, ERK1/2 phosphorylation and 
calcium mobilization was intact in the SCID-patient, yet CD69 and most proliferative 
responses were reduced. However, the proliferative responses to allo-antigen were intact 
(Goldman et al., 1998) as reported previously (Yamada et al., 1997). Altogether, these 
studies indicate that loss of Lck can result in congenital immunodeficiency and selective 
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CD4 lymphopenia. This separates human T cell development from that of mice, since mice 
deficient in p56lck show a substantial reduction in CD4+/CD8+ thymocytes with the 
development of only a small number of peripheral single positive T cells (Molina et al., 
1992).
Lck is the target of many viral proteins, especially the tyrosine kinase interacting protein Tip 
of Herpesvirus saimiri (HVS), and Nef encoded by the Human immunodeficiency virus 
(HIV). The oncoprotein Tip physically interacts with Lck in HVS transformed cells, and 
augments Lck activity independently of Y394 and/or Y505 phosphorylation (Wiese et al., 
1996; Hartley et al., 1999). Tip induces peripheral T-cell lymphoma in transgenic mice 
(Wehner et al. 2001). Nef contributes to HIV disease pathogenesis by augmenting virus 
replication and disturbing T cell function. Nef binds and inhibits Lck, and MAPK kinase 
activity (Greenway et al., 1996), but simultaneous overexpression of Nef has been shown to 
increase T cell ERK1/2 phosphorylation in a calcium-independent manner (Schrager et al., 
2002). Furthermore, Nef synergizes with PMA in inducing NFAT activation, an effect that 
is independent of Lck (Manninen et al., 2002). According to these data it appears that the 
Ras pathway rather than the calcium pathway is the rate-limiting step in TCR-mediated 
NFAT induction. The suceptibility of T cells to HIV infection has been inversely correlated 
with Lck activity (Yousefi et al., 2003). HIV binds to CD4 through gp120 (Juszczak et al., 
1991), and internalization of gp120 is associated with down-modulation of membrane CD4 
and Lck together with impairment of T cell activation (Cefai et al., 1992). Reduced levels of 
Lck but increased levels of Fyn may play a role in the anergic response observed early 
during HIV infection (Cayota et al., 1994). 
Reduced Lck levels have also been shown in some type 1 diabetic patients. Interestingly, 
both ZAP-70 and PLCȖ1 recruitment and phosphorylation was relatively normal, despite 
reduced phosphorylation of CD3ȗ (Nervi et al., 2000). Furthermore, T cells from the 
synovial fluid of rheumatoid arthritis patients displayed lower levels of Lck protein, and 
components of the TCR/CD3-complex (Romagnoli et al., 2001). This downregulation 
correlated with hyporesponsiveness of the T cells. Lastly, Lck has also been shown to be 
downregulated in Alzheimer disease, and was identified as a risk gene for this disease 
(Zhong et al., 2005). 
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3.5. CD3 chain ITAMs 
Immunoreceptor tyrosine-based activation motifs (ITAMs) are 
found within the intracellular portions of the CD3 chains, and are 
the principal substrates for Lck in T cell signaling (Barber et al. 
1989; Irving et al., 1993, Iwoshima et al., 1994, van Oers et al., 
1996b). ITAMs have the concensus sequence YXXL/IX(6-
8)YXXL/I (Reth, 1989), and CD3ȗ contains three repititions of 
of this motif, whereas the  Ȗ, į and İ-chains contain only one 
(Reviewed in Pitcher et al., 2003, and Pitcher and van Oers, 
2003). Each doubly phosphorylated ITAM may recruit the 
tandem SH2 (Src homology 2) domains of ZAP-70 (Chan et al., 
1991; Wange et al., 1992; Wange et al., 1993; Iwashima et al., 
1994) (Fig. 3). ZAP-70 is a Syk family tyrosine kinase which is activated through 
phosphorylation by Lck on Y443 (Chan et al., 1995; Kong et al., 1996) and 
autophosphorylation on many sites, most importantly Y319 (Pelosi et al., 1999; Di Bartolo 
et al., 1999; Williams et al., 1999). The main substrate of ZAP-70 is the Linker for 
Activation of T cells (LAT) (Zhang et al., 1998) (see chapter 3.6). Loss of ZAP-70 disrupts 
TCR signaling and T cell development (Negishi et al., 1995; Williams et al., 1998), 
although ZAP-70-independent signaling has also been shown (Shan et al. 2001). 
Figure 3. CD3ȗ
In thymocytes and peripheral T cells, ITAMs are constitutively tyrosine phosphorylated on 
some residues (van Oers et al., 1993; van Oers et al.; 1994; Pitcher et al., 2003), and it 
appears that Lck or Fyn may fulfill the function of partly phosphorylating ITAMS in resting 
T cells equally well (Seddon and Zamoyska, 2002). ZAP-70 binds to these phosphorylated 
ITAMs but is not activated. Whether this pool of ZAP-70 transduces low level signals 
necessary for T cell survival, primes T cells for activation, or merely protects the ITAMs 
from other proteins, is currently unknown (reviewed in Zamoyska et al., 2003). 
Mutational analysis has revealed redundancy between various chains of the CD3 complex. 
CD3 Ȗİ/įİ provides normal T cell functions in the absence of CD3ȗ (Wegener et al., 1992; 
van Oers et al., 1998, Ardouin et al., 1999; van Oers et al., 2000), and TCR signaling is not 
qualitativly affected by crippling of the CD3İ ITAM (Sommers et al., 2000). The migration 
of unphosphorylated CD3ȗ is 16 kD, and depending on increasing tyrosine phosphorylation, 
21 and 23 kD forms also appear. The six tyrosine residues in ITAM1-3 are numbered Y1-6 
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counting from the N-terminal membrane proximal part. The kinetics of CD3ȗ
phosphorylation has been studied to great extent, with some conflicting findings. It is 
thought that a hierarchic pattern of phosphorylation exists, where phosphorylated ITAM2 
and 3 correspond to p21, whereas full phosphorylation correspons to p23 (Kersh et al., 
1998a; van Oers et al., 2000). Differential signaling occurs from truncated or tyrosine-to-
phenylalanine mutations in CD3ȗ ITAMs, and partially phosphorylated CD3ȗ can inhibit 
(Kersh et al., 1999), variably affect (Chae et al., 2004) or not affect (Ardouin et al., 1999) T 
cell activation. Some reports indicate that proteins such as Grb2, Shc and SOS may be 
recruited to hypophosphorylated ITAMs (Ravichandran et al., 1993; Osman et al., 1995; Nel 
et al., 1995; Labadia et al., 1996; Zenner et al., 1996; Chau and Madrenas 1999). This kind 
of signaling from CD3ȗ may be relevant under certain physiological settings, for example, it 
has been shown that various TCR binding affinities may mediate differential 
phosphorylation of the CD3ȗ chains, leading to anergy in some cases (Sloan-Lancaster et 
al., 1994; Madrenas et al., 1995; Kersh et al., 1998b). Hypophosphorylation of CD3ȗ and 
alternative signaling mechanisms are addressed in paper II. 
3.6. LAT and downstream signaling 
Activated CD3-bound ZAP-70 maintains the 
tyrosine phosphorylation cascade by 
phosphorylating LAT (Zhang et al., 1998; 
Weber et al., 1998) and SLP-76 (Wardenburg 
et al., 1996). LAT is a transmembrane protein 
which concentrates in lipid rafts (Lin et al., 
1999). It contains ten pY residues, where 
Y127, Y132, Y171 Y191 and Y226 (human 
sequence) are the most important (Zhang et 
al., 2000; Sommers et al., 2001; Paz et al., 
2001; Lin and Weiss, 2001). LAT serves as a 
docking site to which a number of adapter and 
signaling molecules bind through SH2 
domains (Grb2, Gads, PLCȖ1 and PI3K), or 
indirectly via adapters (SLP-76, Vav-1, SOS and Itk) (Zhang et al., 1998; Finco et al., 1998; 
Zhang et al., 1999a; Liu et al., 1999; Shan and Wange, 1999; Zhang et al., 2000; Bunnell et 
Figure 4. LAT signaling 
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al., 2000;  Ching et al., 2000; Paz et al., 2001; Lin and Weiss, 2001) (See Fig. 4). LAT is 
essential for TCR signaling as LAT-deficient mice have a block in thymocyte development 
at the immature stage and completely lack mature peripheral T cells (Finco et al., 1998; 
Zhang et al., 1999). SLP-76 is of particular importance for the LAT signaling scaffold. It 
binds LAT through Gads and is phosphorylated by ZAP-70 (Wardenburg et al., 1996). 
Phosphorylated SLP-76 provides binding for the Tec family kinase Itk which is imperative 
for full PLC Ȗ1 activation (Yablonski et al., 1998; Irvin et al., 2000; Bogin et al., 2007). As 
such, from SLP-76 and Itk knockout mice have similar phenotypes, and display disturbed 
PLCȖ1 activity, Ca2+ mobilization and IL-2 production (Liao and Littman, 1995; Clements 
et al., 1998; Pivniouk et al., 1998). Fully activated PLCȖ1 (pY783) catalyses the formation 
of IP3 and DAG (Downward et al., 1990), where the former leads to intracellular Ca2+
influx, and the latter recruits conventional and novel PKCs and RasGRP. RasGRP and SOS 
are guanine nucleotide exchange factors (GEFs), and catalyse the binding of GTP on the 
small G protein Ras. RasGRP has been shown to be the most important GEF in T cells 
(Ebinu et al., 2000; Priatel et al., 2002; Roose et al., 2005), although Grb2-SOS has also 
been implicated (Ravichandran et al., 1993), and especially upon partial agonist stimulation 
(Chau and Madrenas, 1999). Recent data indicate interplay between SOS1 and RasGRP in T 
cell Ras activation (Roose et al., 2007). Ras-GTP activates Raf-1, which phoshorylates 
MEK, leading to ERK phosphorylation. Phosphorylated ERK in turn activates c-Fos and c-
Jun which constitute the AP-1 transcription factor dimer (Su and Karin, 1996). The novel 
type calcium-independent PKCș is critical in the activation of NFțB in T cells (Sun et al., 
2000). PKCș is unique in its ability to localize to the supramolecular activation clusters of 
the TCR/CD3 complex (Monks et al., 1997; Monks et al., 1998). where it is phosphorylated 
and activated by Lck (Liu et al., 2000). Once active, PKCș activates IkB kinase (IKK) 
(Coudronniere et al., 2000, Lin et al., 2000), through the phosphorylation of CARMA1 
(Sommer et al., 2005; Matsumoto et al., 2005) and recruitment of the Bcl10–MALT1 
complex. Activated IKK phosphorylates IțB (Brown et al., 1995; Traenckner et al., 1995), 
marking it for ubiquitination and proteosomal degradation (Chen et al., 1995; Scherer et al., 
1995). When released from inhibition by  IțB, the transcription factor NFțB is free to 
translocate into the nucleus (May and Ghosh, 1998). On the other hand, the transcription 
factor NFAT translocates to the nucleus upon dephosphorylation by Calcineurin, a 
phosphatase activated by Ca2+ bound to calmodulin (Jain et al., 1993; Aramburu et al. 1998; 
Peng et al. 2001). NFAT, AP-1 and NFțB promote the transcription of a number of genes, 
most importantly IL-2, a cytokine which promotes long term proliferation of activated T 
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cells (Zhang and Nabel, 1994). Signal transduction from the TCR and CD28 also lead to 
cytoskeletal rearrangements, involving proteins such as Vav1, Cdc42, Rac-1 and WASP 
(Stowers et al., 1995; Holsinger et al., 1998; Sedwick et al., 1999; Snapper and Rosen, 
1999). These rearrangements are important for integrin signaling and formation of the 
immunological synapse.
3.7. Lck and inhibition of T cell signaling 
Figure 5. Negative regulation  of 
TCR signaling through Lck 
Interestingly, Lck has also been linked to negative 
regulation of TCR signaling (fig. 5). Some early 
reports suggested that the kinase function of Lck 
was not required for CD4-dependent T cell 
activation (Collins and Burakoff, 1993) or that 
deletion of the kinase domain even lead to 
hyperactivity (Xu and Littman, 1993). Engagement 
of the TCR with antagonists increased the activity 
of CD4-associated Lck without leading to T cell 
activation (Racioppi et al., 1996; Haughn et al., 
1992). Such T cells become anergic, and this indicates a negative role for Lck. Interestingly, 
it has been shown that triggering of the T cell antigen receptor by superantigens, such as 
staphylococcal enterotoxins, occurs independently of Lck (Yamasaki et al., 1997). In fact, 
JCaM1 cells lacking Lck, or human T cells pretreated with the PP2, are strongly 
hyperresponsive to SEE stimulation (Criado and Madrenas, 2004). This reveals a negative 
contribution of Lck to T cell activation, an effect that is dependent on its kinase activity. It 
was recently shown that superantigen triggering of the TCR activated  PLCȕ in a GĮ11-
dependent manner, and this resulted in robust ERK1/2 activation in Lck-deficient cells 
(Bueno et al., 2006). Other examples of Lck-independent signaling and negative regulation 
can also be found in the literature. For example, inhibition of Lck by antisense RNA in Th2 
cells leads to elevated levels of lymphokine mRNAs, including IL-4, IL-5, and IL-10, and 
these cells were capable of secreting IL-4 upon activation through the TCR (Al-Ramadi et 
al., 1996). This occured despite abolished phosphorylation of CD3ȗ and ZAP-70 and 
defective Ca2+ mobilization to antigenic stimuli. These data indicate that Lck-independent 
pathways of gene induction exist, a concept which we explored further in papers I and II. 
The negative role implicated for Lck is emphasized by its involvement in ligand-induced 
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TCR internalization (Luton et al., 1994; D’Oro et al., 1997; Lee et al., 1997; Salio et al., 
1997) and activation-induced cell death (Yu et al., 2004).  These data suggest that Lck may 
be important for regulating the availability of TCR and the magnitude of T cell signaling. 
Apoptotic pathways are also dependent on Lck (see chapter 3.7.5.). In paper III we 
investigated TCR turnover in T cells with low levels of Lck. 
3.7.1. Negative regulators of TCR signaling 
Inhibitory signaling is an important aspect of TCR signaling. In resting cells, inhibitory 
mechanisms keep the cell at rest, preventing aberrant immune activation. When the TCR of 
primary T cells is engaged without the secondary CD28 signal, negative feedback 
mechanisms trigger pathways rendering the cell anergic. T cells undergoing thymic 
education become apoptotic if triggered by autoantigens (clonal deletion). T cells react 
differently depending on the strength and duration of TCR engangement, or to paracrine 
cytokines and cell-cell contacts with other immune cells. A balance of activating and 
inhibiting pathways are important for this fine tuning of T cell responses. The tyrosine 
phosphorylation cascade outlined in chapters 3.3-3.6 reaches its peak after about 2-3 
minutes of TCR/CD3 stimulation. Likewise, the MAP kinases ERK1/2 reach their 
maximum phoshorylation within 3 minutes. After this peak most phosphorylation levels 
decline rapidly through the action of phosphatases and protein degradation, and are down to 
basal after about 30 minutes of TCR stimulation. Failures in these inhibitory mechanisms 
may lead to aberrant T cell responses, facilitating autoimmune diseases or cancer 
developement. 
3.7.2. SHP-1 
The function of the tyrosine phosphatase SHP-1 is an instructive example of negative T cell 
signaling (reviewed in Zhang J. et al., 2000). It is expressed at high levels in hematopoietic 
cells of all lineages, and altered expression and/or structure of SHP-1 plays a role in the 
progress of many forms of leukemia. Thymocytes from moth-eaten mice with reduced 
levels of SHP-1 show increased activation of Lck and Fyn, and develop a severe 
autoimmune and immunodeficiency syndrome with hyperactive T cells (Lorenz et al., 
1996). SHP-1 is activated by engagement of its tandem SH2 domains by phosphotyrosines 
(Pei et al., 1994), and Lck-mediated phosphorylation of Y536 and Y564 (Lorentz et al., 
1994, Frank et al., 2004). SHP-1 in turn serves to deactivate Lck by dephosphorylating 
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Y394 (Chiang et al., 2001), and also dephosphorylates other effectors of T cell signaling
such as ZAP-70 (Plas et al., 1996, Brockdorff et al., 1999), Vav1 (Pani et al., 1996; Kon-
Kozlowski et al., 1996),  SLP-76 (Binstadt et al., 1998) and CD3ȗ (Sozio et al. 2004). 
Furthermore, SHP-1 participates in fine tuning of TCR signals, as demonstrated by low 
affinity ligands which trigger binding of the SHP-1 to Lck. This negative feedback is 
circumvented by stronger ligands through phosphorylation of S59 in Lck in an ERK-
dependent manner, which prevents SHP-1 binding and inhibition (Stefanova et al., 2003). 
The impact of Lck-kd on SHP-1 activity was addressed in Paper I. 
3.7.3. Ras-GAP 
The Ras GTPase p120 Ras-GAP is a negative regulator of Ras signaling acting by 
accelerating the hydrolysis of Ras-GTP to Ras-GDP. Ras-GAP is thought to be activated by 
membrane recruitment and tyrosine phosphorylation on several residues, most importantly 
Y460 (Liu and Pawson, 1991; Amrein et al., 1992, Park et al., 1993). There has been some 
controversy regarding the effects of Ras-GAP phosphorylation by Lck (Amrein et al., 1994, 
Giglione et al., 2001). Recently it was shown that Ras-GAP interacts with Cbp/PAG in 
stimulated T cells, suppressing Ras activation (Smida et al., 2007). This effect was shown to 
be independent of Csk binding. The phosphorylation and recruitment of Ras-GAP in the 
context of Lck knockdown was investigated in Paper II. 
3.7.4. Cbl 
The E3 ubiquitin ligase Cbl functions as a negative regulator of many signaling pathways. 
Cbl exists in two main isoforms, c-Cbl and Cbl-b, with a high level of sequence 
conservation. c-Cbl is activated by tyrosine phosphorylation on several residues, most 
importantly Y700, Y731 and Y774 (Hunter et al., 1999; Donovan et al., 1994; Feshchenko 
et al., 1998; Kassenbrock and Anderson, 2004). These residues are not, however, substrates 
of Lck or ZAP-70, but of Fyn and Syk (Hunter et al., 1999; Feshchenko et al., 1998; 
Tsygankov et al., 1996; Deckert et al., 1998), which are activated directly or indirectly by 
Lck (Filipp et al., 2003). Engagement of the TCR leads to activation of T cells, but also 
internalization and lysosomal degradation of the receptor complex (Valitutti et al., 1997). 
This serves to terminate signaling, and this process is dependent on the tyrosine kinase 
activity of Lck (Luton et al., 1994; D’Oro et al., 1997) and ubiquitination by c-Cbl (Hou et 
al., 1994; Cenciarelli et al., 1996; Wang et al., 2001, Naramura et al., 2002). Ubiquitination 
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marks active enzymes and receptors for degradation (reviewed in Thien and Langdon, 2005 
and Swaminathan and Tsygankov, 2006). Cbl-dependent ubiquitination requires interaction 
with the target protein. For example, c-Cbl and Lck interact through binding of proline-rich 
seqences in Cbl with the SH3 domain in Lck. The SH2 domain of Lck also binds to 
phosphorylated sites in Cbl, and the Cbl TKB domain binds to the activation loop 
phosphorylation site in Lck after stimulation of T cells (Rao et al., 2002). Other notable 
targets for c-Cbl-mediated ubiquitination are Vav (Miura-Shimura et al., 2003), Fyn 
(Yokouchi et al., 2001; Andoniou et al., 2000; Hunter et al., 1999), ZAP-70 (Lupher et al., 
1996), as well as the already mentioned TCR/CD3-complex. Consistent with the negative 
regulation assigned to the Cbl family of proteins, T cells from c-Cbl-/- and Cbl-b-/- mice were 
hyperactive upon TCR engagement, although some biochemical distinctions between the 
phenotypes existed (Murphy et al., 1998; Naramura et al., 1998; Thien et al., 1998; 
Bachmaier et al., 2000; Chiang et al., 2000). T cells from double-knockout (dKO) mice 
lacking both c-Cbl and Cbl-b, failed to modulate surface TCR after ligand engagement, 
resulting in sustained TCR signaling and ERK1/2 phosphorylation. However, signaling 
through the major TCR pathways were not increased (Naramura et al., 2002). The impact of 
reduced Lck levels on c-Cbl activity and TCR/CD3 turnover was investigated further in 
Paper III. 
3.7.5. Bak 
Bak is a pro-apoptotic member of the Bcl-2 family of proteins, and participates in the 
mitochondrial pathway of apoptosis. JCaM1 cells were shown to completely lack Bak, an 
effect that was reversed upon reconstitution with Lck (Samraj et al., 2006). This and other 
studies have shown that T cells lacking Lck are resistant to apoptosis induced by many 
kinds of stimuli (Di Somma et al., 1995; Oyaizu et al., 1995; Belka et al., 2003; Hur et al., 
2004; Gruber et al., 2004). Interestingly, the effect of Lck on Bak transcription was 
independent of the kinase domain of Lck and classical mediators of T-cell signaling such as 
ZAP-70 and LAT (Samraj et al., 2006). Most research regarding Lck has focused on its 
capacity as a tyrosine kinase, but these data indicate that Lck also participates in other kinds 
of signaling, where the presence of Lck is required for the transcription of other proteins. 
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3.8. Heterotrimeric G proteins and T cell signaling 
Heterotrimeric G proteins consist of an Į-subunit that binds and hydrolyzes GTP, and ȕ- and 
Ȗ-subunits that form an undissociable ȕȖ-complex. Coupling between an activated G-
protein-coupled receptor (GPCR) and its G protein promotes the exchange of GDP for GTP 
on the Į-subunit. This allows the Į-subunit and the ȕȖ-complex to dissociate and modulate 
the activity of a variety of effectors such as ion channels and enzymes (reviewed in 
Offermanns, 2000). T cells express most GĮ-subunits of the GĮs, GĮi, GĮq/o and GĮ12
families (Offermanns et al., 2001), and heterotrimeric G proteins have been implicated in T 
cell signaling in several reports (Cenciarelli et al., 1992; Sancho  et al., 1993; Stanners et al., 
1995; Zhou et al., 1998; Tsoukas et al., 2000; Lippert et al., 2000). For example, it has been 
shown that activation of primary T cells lead to recruitment of GĮs and GĮq to lipid rafts 
(Abrahamsen et al., 2004), and crosstalk between heterotrimeric G-proteins and different 
tyrosine kinases has been reported in several cell types (Luttrell et al., 1996; Luttrell et al., 
1997; Luttrel et al., 1999; Luttrell et al., 2004). Src can be activated directly by GĮs or GĮi
through binding binding of the G protein to the catalytic domain of Src (Ma et al., 2000), 
and Lck can also be regulated positively by the same GĮs-dependent mechanism (Gu et al., 
2000). Cross-talk between the GĮq and Lck has been reported (Inngjerdingen et al. et al., 
2002). Transfection with a function deficient mutant of GĮq/11 impared phosphorylation of 
CD3ȗ and ZAP-70 (Stanners et al. 1995). A recent report shows that JCaM1 cells lacking 
Lck may be activated through a GĮ11-dependent mechanism, mediated through PLCȕ1
activation (Bueno et al., 2006). The involvement of G proteins in T cell signaling and the 
interplay between G proteins and Lck was explored in paper IV. 
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4. Aims of the present study 
In this thesis we wanted to investigate the molecular mechanisms responsible for regulation 
of TCR-induced signaling mediated through the Src kinases Lck and Fyn, and the 
heterotrimeric G proteins GĮs, GĮi-2 and GĮq.
The main objectives of the present study were to: 
1.   Generate siRNAs for the SFKs Lck and Fyn, as well as the heterotrimeric G proteins 
GĮs, GĮi-2 and GĮq, and validate these siRNAs with respect to potency and specificity in 
both Jurkat and primary human T cells. 
2.   Explore the impact of Lck knockdown in T cells, and hereunder: 
a) Characterize the observed paradoxical hyperresponsive Lck-kd phenotype using 
standard biochemical assays. 
b) Investigate possible alternative mechanisms of T cell activation. 
c) Study the involvement of Lck in negative T cell signaling. 
3.   Investigate the involvement of heterotrimeric G proteins in T cell signaling, with 
particular emphasis on their possible crosstalk with Lck. 
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5. Synopsis of papers 
Paper I: 
Short-interfering RNA-mediated Lck knockdown results in augmented downstream T 
cell responses. Here, we designed, synthesized and validated four siRNAs and one control 
siRNA for Lck and Fyn respectively. We obtained highly efficient knockdown in both 
Jurkat and primary human T cells using low doses of siRNA (100 nM). By using other 
siRNAs we controlled for off-target effects. As expected, proximal signaling was reduced 
with Lck-kd as determined by overall tyrosine phosphorylation, CD3ȗ phosphorylation and 
Ca2+ mobilization. Surprisingly, we observed augmented activation of NFAT-AP-1 and 
sustained phosphorylation of ERK1/2 in Jurkat cells, and increased secretion of IL-2 in 
primary T cells. We found that the phosphatase activity of SHP-1 was reduced in Lck-kd 
cells, and we speculated whether alternative mechanisms of activation could be in operation, 
possible mediated through ERK as we observed sustained phosphorylation of this MAPK. 
Fyn did not seem to be responsible for this mechanism since co-knockdown of Fyn did not 
reverse hyperresponsiveness in Lck-kd cells. 
Paper II: 
Hypophosphorylated TCR/CD3-zeta signals through a Grb2-SOS1-Ras pathway in 
Lck knockdown cells. In this study we presented an alternative mechanism of TCR 
signaling in T cells with Lck-kd. We reported the recruitment of Grb2-SOS1 to CD3ȗ after 
prolonged stimulation of Lck-kd cells. In line with this, Ras, Raf-1 and ERK1/2 displayed 
sustained activation. In a solid phase assay, Grb2 bound to incompletely phosphorylated 
ITAM1 with the pY-Y configuration, but was competed by ZAP-70 with respect to binding 
to the doubly phosphorylated pY-pY conformation of the ITAMs. We also found that the 
phosphorylation of Ras-GAP was strongly suppressed in Lck knockdown cells, indicating 
that a Ras negative feedback mechanism is dependent on Lck. 
Paper III: 
Normal TCR/CD3 endocytosis but reduced CD3-zeta degradation despite diminished 
Cbl phosphorylation in T cells with low Lck levels. In this report we investigated further 
how low levels of Lck may result in aberrant T cell signaling. c-Cbl phosphorylation was 
strongly reduced in T cells with Lck knockdown, as was ubiquitination of CD3ȗ.
Surprisingly, endocytosis of the T cell receptor complex occured normally, but confocal 
microscopy showed that CD3ȗ containing vesicles were not targeted for lysosomal 
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degradation to the same degree as in control cells. This led to reduced degradation of CD3ȗ,
and we hypothesized that prolonged cytosolic subsistence of the T cell receptor complex 
could result in extended signaling in T cells with Lck knockdown. 
Paper IV: 
GĮq regulates TCR-mediated immune response in T cells through an Lck-dependent 
pathway. In this paper we showed that GĮs and and GĮq, but not GĮi-2 were activated 
upon anti-CD3 stimulation, and we targeted GĮs, GĮi-2 and GĮq with siRNA-mediated 
knockdown to examine their roles in TCR sigaling. GĮs-kd and GĮi-2-kd did not result in 
any significant changes, but GĮq-kd reduced Lck activity significantly. Despite this, NFAT-
AP-1 and ERK1/2 phosphorylation were augmented. Similarly, primary T cells from GĮq-/-
mice displayed reduced proximal signaling, but augmented secretion of IL-2, IL-5, IL-12 
and TNF-Į. The hyperresponsivenss in GĮq-kd cells was reversible when cells were 
transfected with constitutively active Lck Y505F or pretreated with PP2. We speculated that 
GĮq has a key regulatory role in T cell signaling acting at the level of Lck. 
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6. Discussion 
6.1. The Lck knockdown phenotype 
6.1.1. Low levels of Lck and alternative signaling mechanisms 
Recruitment of other proteins than ZAP-70 to hypophosphorylated CD3ȗ ITAMs has been 
suggested previously, but not in the context of Lck knockdown. (Ravichandran et al., 1993, 
Osman et al., 1995, Nel et al., 1995, Labadia et al., 1996, Zenner et al., 1996, Chau et al., 
1999). Chau and Madrenas (1999) proposed that partial agonists may trigger Grb2-SOS 
binding to hypophosphorylated CD3ȗ in the absence of LAT phosphorylation. Similarly, we 
propose that low levels of Lck may give rise to hyperresponsive signaling through CD3ȗ-
Grb2-SOS1 when negative feedback through SHP-1, Ras-GAP and c-Cbl is displaced 
(Paper I-III). An important question is why T cells treated with pharmacological inhibitors 
to Lck such as PP2, or cells overexpressing Csk, do not display a similar hyperactivity in 
response to anti-CD3 ligation. Such treatments also reduce the kinase activity of Lck, but 
they do not result in an hyperactive response as described for Lck-kd.
It is becoming clear that Lck does not function exclusively as a tyrosine kinase. Lck is also 
an important adapter protein, and participates in signaling pathways not directly related to 
the TCR. It was recently reported that the transcriptional activation of the pro-apoptotic 
protein Bak was dependent on Lck (Samraj et al., 2006). The authors concluded that this 
effect was independent of the kinase domain of Lck, PP2 treatment, and classical mediators 
of T-cell signaling such as ZAP-70 and LAT. How Lck confers its influence on Bak 
expression remains undetermined. In another report, JCaM1 cells expressing a mutated form 
of Lck lacking the SH3 domain, failed to activate ERK1/2 despite normal TCR  chain 
phosphorylation, ZAP-70 recruitment, and ZAP-70 activation (Denny et al., 1999). In 
contrast, we show that ERK1/2 becomes activated despite reduced TCRȗ phosphorylation 
and ZAP-70 activation (Papers I and II). These results suggest that Lck participates in more 
than one signaling pathway, and that removal of Lck, or parts of Lck, may result in different 
outcomes than mere inhibition of the protein. This notion is of interest in T cells since most 
of the research conducted on Lck has focused on its capacity as a tyrosine kinase. The 
siRNA-mediated Lck-kd phenotype we have investigated is paradoxical in this respect, and 
alludes to alternative or complementary signaling mechanisms. Whether or not such 
responses are aberrant or physiologically relevant is not known. Acute knockdown of a 
protein is unlikely to occur in a physiological setting. T cells with reduced levels of Lck 
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have been reported from humans in the literature, but these patients have endured long 
lasting lack of Lck activity. The pathologies implicated ranged from immunodeficiency 
(CVID, SCID) to autoimmunity (lupus, diabetes, reumatoid arthritis). Common for most, 
but not all of these cases, was reduced proximal T cell signaling. In some cases, various 
forms of activity was observed, although not hyperresponsiveness as we report. It is 
therefore possible that siRNA-mediated knockdown of Lck results in an experimentally 
induced artificial phenotype. What is interesting, however, is that we have detected an 
alternative signaling mechanism, which may be important for signaling in T cells in other 
contexts. In the study published by Lovatt et al., low levels of Lck produced the same 
degree of MEK and ERK1/2 phosphorylation as Lck-deficient cells. This effect was shown 
to be dependent on Fyn, and they speculated that SOS could be involved in producing Ras 
activation (Lovatt et al., 2006). Clearly, such a notion is interesting in respect to the data 
presented in Paper II. In the classical paradigm of T cell activation, Lck is the exclusive 
conveyer of signal transmission mediated through the TCR. In this framework, Lck is 
activated by TCR engagement and its primary function is to phosphorylate the TCR/CD3-
complex. Genetic, mutational and pharmacological data assembled from fifteen years of 
research indicate that Lck plays an important role, but it is not indispensable for T cell 
signaling, and Lck also participates in negative regulation. Lck-independent signaling 
mechanisms have been shown especially for partial agonist effects (Yamasaki et al., 1997; 
Chau and Madrenas, 1999; Criado and Madrenas, 2004; Bueno et al., 2006). It has also been 
shown that defective Ca2+ signaling blocks NFAT1 translocation, while selectively 
activating NFAT2 in anergic T cells (Srinivasan and Frauwirth, 2007). The field now 
increasingly acknowledges the non-linear dynamics of cellular systems, with increasing 
focus on differential signaling mechanisms, and the more complex role of signal transducers 
such as Lck. 
6.1.2. Lck and apoptosis 
Since Lck has been implicated in apoptosis and activation induced cell death (AICD), we 
hypothesized that reduced apoptosis and/or AICD, could contribute to sustained signaling i 
T cells with low levels of Lck. However, during the course of the experiments conducted in 
Jurkat TAg cells (6 h for the NFAT-AP-1-luciferase assay), no induction of  apoptosis or 
reduction of cell viability was observed after OKT3 stimulation, even with low or high 
dosages (TM, unpublished observations). This was surprising as we found Bak expression 
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to be severely affected by Lck 
knockdown (Fig. 6), in agreement with 
the report by Samraj et al. (2006). 
Activation of Caspase-3 was even 
reduced upon OKT3-stimulation in both 
control and Lck-kd cells, and there was no 
difference in Caspase-3 activation in the 
positive control (FasL treatment) (TM, 
unpublished observations). 
Figure 6. Bak expression in Lck-kd cells 
6.1.3. Endocytosis of TCR/CD3 
As reported in Paper III, we observed no difference in endocytosis of engaged TCR/CD3-
complex in control and Lck-kd cells. This was surprising as previous reports had indicated 
this process to depend on Lck and/or Cbl-mediated ubiquitination for this process to occur 
(Luton et al., 1994, D’Oro et al., 1997, Hou et al., 1994, Cenciarelli et al., 1996, Wang et al., 
2001, Naramura et al., 2002). Seemingly, endocytosis can take place with very low Lck 
and/or Cbl activity, or other mechanisms are involved. The latter scenario seems plausible 
as internalization of the TCR/CD3-complex was completely unaffected by the loss of Lck. 
However, we did observe a significant reduction in lysosomal sorting of CD3-containing 
vesicles in the Lck-kd cells. This suggests that Cbl-mediated ubiquitinylation is required for 
this process, but is dispensable for endocytosis of the TCR. Similar data have been reported 
for the EGF receptor (Duan et al., 2003, Padrón et al., 2007).  
6.2. The involvement of heterotrimeric G proteins in T cell signaling 
As shown in paper IV, triggering of the TCR leads to GTP-binding and thus activation of 
GĮq. The mechanism whereby this occurs is unknown, but probably involves the 
recruitment of a GEF for heterotrimeric G proteins to the membrane, or cross-talk between 
the TCR and a GPCR, perhaps CXCR4 (Peacock and Jirik 1999; Kumar et al., 2006; 
Patrussi et al., 2007). Knockdown of GĮq inhibited Lck autophosphorylation, whereas 
overexpression of a constitutively active mutant of GĮq augmented Lck activity. These data 
alludes to some kind of interplay beween Lck and GĮq, which has been shown previously 
for GĮs and Lck (Gu et al. 2000). Surprisingly, GĮq-kd and GĮq KO augmented 
downstream T cell responses, despite reduced proximal signaling. This effect was reversed 
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to basal levels by PP2, and to the level of stimulated control cells by co-transfection with 
Lck Y505F. This indicates that both reduction and overexpression of GĮq may produce 
Lck-dependent hyperactivity. Furthermore, since Lck Y505 reduced the response in GĮq-kd
cells, but augmented signaling in unstimulated cells, it is likely that Lck contributes both 
negatively and positively to T cell activation. We postulate that TCR stimulation activates 
GĮq which augments Lck activity, whereas GĮq-kd inhibits Lck activity and results in 
signaling through other pathways. 
6.3. Methodological considerations 
6.3.1. siRNA-mediated RNAi 
A publication in 1990 triggered the discussion of co-suppression of endogenous genes by 
transgenes: Overexpression of chalcone synthase, which is responsible for violet coloration 
in petunias, rendered the petunia flowers white (Napoli et al., 1990). dsRNA-mediated gene 
silencing of target mRNA was documented in C.elegans eight years later (Fire et al., 1998), 
a work for which the principal investigators Andrew Fire and Craig Mello received the 
Nobel Prize in 2006. This method has since been employed with success in mammalian 
cells (Elbashir et al., 2001), and T lymphocytes (McManus et al., 2002a, McManus et al., 
2002b), and is now routinely used in biomedical research. Per october 2007, a PubMed 
search returns more than 12.800 hits for “siRNA”. 
The siRNAs used in this thesis are 21-nt duplex oligomers with a 2-nt overhang on each 
end. They were designed and synthesized in-house based on an in-house developed 
algorithm by Amarzguioui et al., (2004). The utility of the RNAi approach depends on 
target specificity and side effects of the treatment. For example, indifferent design or 
secondary RNA structures may cause off-target down regulation of other genes (Bridge et 
al., 2003). siRNAs utilize a molecular machinery already present in the cell, that probably 
evolved to combat RNA viruses. The complete effects of this system, appart from mRNA 
clevage, are still not known in full detail. When introduced into mammalian cells, long 
dsRNAs are fragmented by the protein Dicer. The shorter pieces are used as templates by 
RNA induced silencing complex (RISC) to cleave any complementary RNA sequence in the 
cell, thus disrupting protein translation. However, virus-infected cells may also trigger a 
PKR-interferon response when exposed to dsRNA. This shuts down all protein production 
and induces the production of INFȖ, a cytokine which activates cytotoxic immune cells. 
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This classical anti-viral defence is instigated to avoid transcription of viral proteins and to 
ensure elimination of infected cells. siRNAs are thought to be short enough to evade the 
PKR-interferone effects in vertebrates, but 21-nt siRNAs have been shown to activate these 
mechanisms in a concentration-dependent manner in vitro (Sledz et al., 2003). Such 
problems must be considered whenever using siRNAs, and they must be controlled for as 
thoroughly as possible in biomedical research. The siRNAs used in this thesis were 
examined and validated by the following means: 
1.) All siRNA seqences were blasted towards the human genome to avoid overlap 
with other proteins. 
2.) Control siRNAs were designed for all siRNAs employed. The control siRNAs 
contain a triple G/C switch, and were tested with standard biochemical assays 
(monitoring of NFAT-AP-1 reporter assay, and ERK1/2 phosphorylation), against 
mock transfected cells and another control siRNA (Csk2033M3), to ensure that they 
did not significantly influenced signaling. 
3.) Knockdown cells were compared to control transfected cells in all experiments, 
thus ensuring that introduction of siRNAs per se does not generate unwanted side 
effects.
4.) Dosage and incubation time were optimized for each siRNA to ensure minimum 
RNA load in each cell. For Lck232 and Fyn1059, 100 nM of siRNA and 48 hours of 
incubation post transfection was found to produce optimal knockdown. For 
knockdown of G-proteins, 400 nM siRNA was used. Compared to other studies, both 
100 nM and 400 nM are low (Peter et al., 2007) when taking into account 
transfection efficiency in electroporation and nucleofection used on T cells. This 
indicates high potency of the designed siRNAs.
5.) We monitored several other proteins to verify that knockdown was specific. For 
Lck-kd, the expression of Fyn, Csk, PKCĮ, PLCȖ1, LAT, FAK and Pyk2 was not 
disturbed in siRNA concentrations up to 1500 nM, which was the maximum tested. 
6.) For Lck-kd and GĮq-kd, another siRNA was used to reproduce the main findings. 
No difference in results between the different siRNAs was found, thus minimizing 
the risk of observations being influenced by off-target effects due to secondary 
structures.
7.) For Lck-kd we also performed a selection experiment. Cells were co-transfected 
with a surface marker, and positive cells were selected from control and Lck 
knockdown populations for NFAT-AP-1 luciferase reporter assays. Selected cells 
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were compared to control and negatively selected cells, but no difference in relative 
signaling between Lck knockdown and control cells was observed. As expected, the 
absolute luciferase numbers were higher in the selected population as they contained 
more NFAT-AP-1 cDNA. However, since transfection with siRNAs are about 3-fold 
more efficient than cDNA transfections, and knockdown efficiency is so high, the 
selected cells behaved essentially as the whole cell population, and indeed, the 
knockdown of Lck was similar between the two groups (Paper I). 
8.) We also transfected cells and monitored them for several days. The 
hyperresponsive effect seen in Lck-kd cells was induced upon protein knockdown 
and was completely reversible when protein levels returned to normal, 
approximately 7-9 days post-transfection (Paper III). 
Based on these assays, we propose that the siRNAs used in our studies are properly 
validated, and that the results obtained are primarily due to knockdown of specific proteins, 
not unwanted side effects. Given these premises, siRNA-induced gene silencing have many 
advantages over gene knockout by homologous recombination. Firstly, it is a faster and 
cheaper method, and one can relatively easily knock down more than one protein 
simulatneously. Secondly, the method gives acute knockdown in mature human cells. The 
last point is important as it opposes to knockout animals who may suffer embryonic lethality 
or long term defects from their knockouts. For example, compensatory mechanisms may 
develop over time. The siRNAs used in this thesis have provided potent knockdown 
consistently, and the cells could be used in experiments just 48 h after transfection.  
   This does not preclude that other problems might arise with siRNA induced gene 
silencing. An important factor is that ranges of knockdown are obtained. Since we operated 
with knockdown efficiencies close to 100% this factor is minimized, but it is still possible to 
envision the potential problem: In principle, if western blotting of whole cell lysates show 
90% knockdown of a protein, one can not be sure whether 100% of the cells have 90% 
protein knockdown, or 90% of the cells have 100% knockdown. The most plausible 
scenario is a range of knockdowns ranging from 0% in untransfected cells and close to 
100% in cells with high transfection efficiency. Most biochemical assays are conducted on 
whole cell populations, and effects from certain levels of knockdown may dominate the 
final result. For example, it is possible that certain ranges of Lck knockdown produce 
hyperactive responses, while untransfected cells behave as normal cells, and some cells with 
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very high knockdown are nonresponsive. The end result may indicate augmented signaling, 
even though this is not true for all the cells in the experiment.  
6.3.2. The Jurkat cell model 
In immunology, the Jurkat T cell line (Weiss et al.,  1984) has been used along side other T 
cell lines and primary T cells from mice and humans, as model systems for investigation of 
T cell signaling. A large body of research using both Jurkat cell lines and primary T cells, 
has demonstrated the crucial role of Lck in T cell development and TCR signaling. It is 
therefore surprising to note that Jurkat TAg T cells with siRNA mediated Lck knockdown 
display hyperresponsiveness.  Jurkat TAg T cells are Jurkat E6.1 cells stably transfected 
with Simian virus 40 (SV40) large T antigen (TAg). The complete nature of  SV40 
oncogenic cellular transformation is not completely understood, but it involves the 
manipulation of tumor suppressors and cell cycle regulatory proteins such as the 
retinoblastoma family of proteins, p53 and the transcriptional co-activators p300 and CBP 
(reviewed in Ali et al., 2001). Jurkat TAg and E6.1 cells are thought of as identical in regard 
to TCR signaling characteristics, but TAg cells are more viable and easier to transfect. As a 
control, knockdown of Lck was conducted in Jurkat TAg and E6.1 cells in parallell, and 
NFAT-AP-1 activation was monitored. Surprisingly, Jurkat E6.1 Lck-kd cells were 
completely non-responsive to anti-CD3 ligation, wheras Jurkat TAg Lck-kd cells were 
hyperresponsive (Fig. 7). These conflicting data are not unique to Jurkat cells. A similar 
scenario was reported for HEK293 cells by Lefkowitz et al. in 2002, in which the Ptx-
sensitivity to ȕ-adrenergic ERK1/2 activation was 
shown to vary from 0 to 100% in cell lines 
obtained from various sources (Lefkowitz et al. 
2002). How is it possible that Jurkat TAg cells 
and Jurkat E6.1 cells with Lck-kd give rise to 
completely different phenotypes? Based on data 
from primary human T cells where observations 
are similar to those in obtained in Jurkat TAg we 
have continued to investigate Lck knockdown in 
Jurkat TAg cells, but only reproduction of these 
results by other groups can validate our 
conclusions. Cell lines may accumulate 
0
1
2
3
4
5
Ctrl Lck-kd Ctrl Lck-kd
Jurkat TAg Jurkat E6.1
-/+ OKT3 (1500 ng/ml)
A
ct
iv
at
io
n 
of
 N
FA
T-
A
P
-1
(m
ea
n 
+/
- S
.D
, a
rb
.u
ni
ts
)
Figure 7. Jurkat TAg vs Jurkat E6.1 
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differences over time, and batches of cells may vary from laboratory to laboratory. We have 
reproduced the results from Jurkat TAg cells with other sources to rule out specific 
disorders with our batch. Relative to other cell types, the Jurkat TAg and E6.1 cells are very 
similar, and the two cell lines have been used side by side in experiments for many years. 
This discrepancy warrants a discussion regarding the validity of cell lines, not only in T cell 
signaling, but also in experimental research generally. This also illustrates the necessity of 
validating observations from cell lines in primary human cells or mouse models. We have 
used primary human T cells in Papers I and II, and mouse T cells from knockout mice in 
Paper IV.
6.4. Future perspectives 
Many interesting questions were raised during the work on this thesis, and further 
investigation of complementary or alternative signaling mechanisms in T cells is of interest. 
It is becoming clear that the strictly linear signaling concept of the Lck-CD3-ZAP70-LAT 
pathway is an oversimplification. Various ligand affinities and durations of TCR, CD3, CD4 
and CD28 engagements, may produce different kinds of signaling. Within the Lck 
knockdown model, it would be interesting to monitor more closely differences in activation 
patterns for various of Lck protein levels. For example, it is possible to transfect T cells with 
siRNAs, withdraw cells after various periods of incubation, and analyse the status of many 
phosphoproteins by flow cytometry. By doing this, changes in signaling depending on 
reducing or increasing amounts of Lck can be observed with higher fidelity. 
Furthermore, since the expression of Bak is dependent on the presence of Lck, it would be 
interesting to perform microarray analysis of Lck-kd cells to monitor whether other proteins 
are affected. If other proteins are also regulated, it may bring new insight to the paradoxical 
hyperresponsive signaling we have observed in Lck-kd cells. The mechanism by which Lck 
controls the promoter activity and expression of other proteins is also of importance, since 
this opens up new a aspect of Lck-mediated signaling. 
In Paper III we reported that endocytosis of the TCR/CD3-complex occured normally 
despite reduced Lck and Cbl activity. Seemingly, internalization of the receptor was not 
dependent on Lck/Cbl, or very low levels of activity from these proteins was sufficient for 
this process to occur. Furthermore, even though reduced, colocalization of CD3-containing 
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vesicles with lysosomes was not completely abolished in Lck-kd cells, indicating that 
vesicles can merge with lysosomes independently of ubiquitination. Further investigation of 
the mechanism by which TCR/CD3 is endocytosed, and how these vesicles localize with 
lysosomes, is warranted. The Lck-kd model, and siRNA-mediated knockdown of other 
protens, can be used as a valuable tool for such experiments. For example, what phenotypes 
will knockdown of c-Cbl, or the concurrent knockdown of c-Cbl and Lck produce in this 
respect? 
The question of how the TCR activates GĮq, and how the activated subunit exerts its effect 
on Lck, and vice versa, will be interesting to pursue in future studies. Our data indicate that 
interplay between Lck and GĮq exist, and that they interact physically in T cells. 
Furthermore, signaling through, and crosstalk between TCR and CXCR4 would be 
interesting to investigate using siRNA-mediated knockdown of Lck and G-proteins. 
Finally, the striking difference in signaling observed in Jurkat TAg and Jurkat E6.1. cells 
with Lck-kd should be investigated further. That two similar cell lines can generate 
completely different phenotypes is disturbing, and this finding should be addressed more 
thoroughly in the wider scientific community. 
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7. Conclusions 
1. siRNA-mediated knockdown of the 
Src family kinase Lck, but not Fyn, 
renders T cells hyperresponsive.
2. An alternative signaling pathway is 
activated in T cells with low levels of 
Lck. Prolonged stimulation leads to 
recruitment of Grb2-SOS1 to 
hypophosphorylated CD3ȗ, resulting 
in signaling through Ras-Raf-1-MEK-
ERK.
3. Colocalization of CD3-containing 
vesicles with lysosomes is reduced in 
stimulated T cells with Lck 
knockdown, resulting in prolonged 
subsistence of CD3ȗ.
Figure 8. Alternative signaling pathway in T 
cells with siRNA-mediated Lck knockdown. 
4. Negative regulators of T cell signaling, such as SHP-1, Ras-GAP and Cbl display reduced 
activity in Lck-kd cells. We propose that sustained signaling from CD3ȗ-Grb2-SOS1-Ras-
ERK1/2 in the absence of the negative feedback constraints normally imposed by Lck, may 
result in hyperresponsiveness in T cells with siRNA-mediated Lck knockdown (Fig. 8). 
5. We report interplay between Lck and GĮq. GĮq appears to enhance Lck activation upon 
TCR triggering. Knockdown of GĮq renders T cells hyperresponsive possibly due to 
sustained ERK signaling. Altogether this indicates a regulatory role of this G protein in T 
cell signaling. 
41
8. References 
Abraham KM, Levin SD, Marth JD, Forbush KA, and Perlmutter RM. 1991. Thymic tumorigenesis induced 
by overexpression of p56lck. Proc. Natl. Acad. Sci. U. S. A. 88:3977-3981. 
Abraham N and Veillette A. 1990. Activation of p56lck through mutation of a regulatory carboxy-terminal 
tyrosine residue requires intact sites of autophosphorylation and myristylation. Mol. Cell. Biol. 10:5197-5206. 
Abrahamsen H, Baillie G, Ngai J, Vang T, Nika K, Ruppelt A, Mustelin T, Zaccolo M, Houslay M, and 
Taskén K. 2004. TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR 
signaling. J. Immunol. 173:4847-4858. 
Ali SH., and DeCaprio JA. 2001. Cellular transformation by SV40 large T antigen: interaction with host 
proteins. Semin. Cancer Biol. 11:15-23 
al-Ramadi BK, Nakamura T, Leitenberg D, and Bothwell AL. 1996. Deficient expression of p56(lck) in Th2 
cells leads to partial TCR signaling and a dysregulation in lymphokine mRNA levels. J Immunol. 157:4751-
4761.  
Amarzguioui M, and Prydz H. 2004. An algorithm for selection of functional siRNA sequences. Biochem. 
Biophys. Res. Commun. 316: 050-1058. 
Amrein KE, Flint N, Panholzer B, and Burn P. 1992. Ras GTPase-activating protein: a substrate and a 
potential binding protein of the protein-tyrosine kinase p56lck. Proc. Natl. Acad. Sci. U. S. A.  89: 3343-3346. 
Amrein KE, Panholzer B, Molnos J, Flint NA, Scheffler J, Lahm HW, Bannwarth W, and Burn P. 1994. 
Mapping of the p56lck-mediated phosphorylation of GAP and analysis of its influence on p21ras-GTPase 
activity in vitro. Biochim. Biophys. Acta. 1222:441-446. 
Amrein KE, Sefton BM. 1988. Mutation of a site of tyrosine phosphorylation in the lymphocyte-specific 
tyrosine protein kinase, p56lck, reveals its oncogenic potential in fibroblasts. Proc. Natl. Acad. Sci. U. S. A.
85:4247-4251.  
Andoniou CE, Lill NL, Thien CB, Lupher ML, Ota S, Bowtell DD, Scaife RM, Langdon WY, and Band H. 
2000. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing 
its degradation. Mol. Cell. Biol. 20:851-867. 
Appleby MW, Gross JA, Cooke MP, Levin SD, Qian X, and Perlmutter RM. 1992. Defective T cell receptor 
signaling in mice lacking the thymic isoform of p59fyn. Cell. 70:751-763.   
Aramburu J, Garcia-Cozar F, Raghavan A, Okamura H, Rao A, Hogan PG. 1998. Selective inhibition of 
NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol. Cell. 1:627-637. 
Ardouin L, Boyer C, Gillet A, Trucy J, Bernard AM, Nunes J, Delon J, Trautmann A, He HT, Malissen B, and 
Malissen M. 1999. Crippling of CD3-zeta ITAMs does not impair T cell receptor signaling. Immunity. 10:409-
420.  
Autero M, Heiska L, Rönnstrand L, Vaheri A, Gahmberg CG, and Carpén O. 2003. Ezrin is a substrate for Lck 
in T cells. FEBS Lett. 535:82-86. 
Bachmaier K, Krawczyk C, Kozieradzki I, Kong YY, Sasaki T, Oliveira-dos-Santos A, Mariathasan S, 
Bouchard D, Wakeham A, Itie A, Le J, Ohashi PS, Sarosi I, Nishina H, Lipkowitz S, and Penninger JM. 2000. 
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature.
403:211-216. 
Barber EK, Dasgupta JD, Schlossman SF, Trevillyan JM, and Rudd CE. 1989. The CD4 and CD8 antigens are 
coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex. Proc. Natl. Acad. Sci. U. 
S. A. 86:3277-3281. 
42
Belka C, Marini P, Lepple-Wienhues A, Budach W, Jekle A, Los M, Lang F, Schulze-Osthoff K, Gulbins E, 
and Bamberg M. 1999. The tyrosine kinase lck is required for CD95-independent caspase-8 activation and 
apoptosis in response to ionizing radiation. Oncogene. 18:4983-4992.   
Bergman M, Mustelin T, Oetken C, Partanen J, Flint NA, Amrein KE, Autero M, Burn P, and Alitalo K. 1992. 
The human p50csk tyrosine kinase phosphorylates p56lck at Tyr-505 and down regulates its catalytic activity. 
EMBO J. 11:2919-2924.   
Binstadt BA, Billadeau DD, Jevremovic D, Williams BL, Fang N, Yi T, Koretzky GA, Abraham RT, and 
Leibson PJ. 1998. SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. J. Biol. 
Chem. 273:27518-27523.   
Bogin Y, Ainey C, Beach D, and Yablonski D. 2007. SLP-76 mediates and maintains activation of the Tec 
family kinase ITK via the T cell antigen receptor-induced association between SLP-76 and ITK. Proc. Natl. 
Acad. Sci. U. S. A. 104:6638-6643.  
Brdicka T, Pavlistova D, Leo A, Bruyns E, Korinek V, Angelisova P, Scherer J, Shevchenko A, Hilgert I, 
Cerny J, Drbal K, Kuramitsu Y, Kornacker B, Horejsi V, and Schraven B. 2000. Phosphoprotein associated 
with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor 
protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J. Exp. Med.
191:1591-1604.  
Brdickova N, Brdicka T, Angelisova P, Horvath O, Spicka J, Hilgert I, Paces J, Simeoni L, Kliche S, Merten 
C, Schraven B, and Horejsi V. 2003. LIME: a new membrane Raft-associated adaptor protein involved in CD4 
and CD8 coreceptor signaling. J. Exp. Med. 198:1453-1462.  
Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, and Iggo R. 2003. Induction of an interferon response by 
RNAi vectors in mammalian cells. Nat Genet. 34:263-264. 
Brockdorff J, Williams S, Couture C, and Mustelin T. 1999. Dephosphorylation of ZAP-70 and inhibition of T 
cell activation by activated SHP1. Eur J Immunol. 29:2539-2550. 
Brown K, Gerstberger S, Carlson L, Franzoso G, and Siebenlist U. 1995. Control of IțB-Į proteolysis by site-
specific, signal-induced phosphorylation. Science. 267:1485– 1488. 
Bueno C, Lemke CD, Criado G, Baroja ML, Ferguson SS, Rahman AK, Tsoukas CD, McCormick JK, and 
Madrenas J. 2006. Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a 
Galpha11-dependent, PLC-beta-mediated pathway. Immunity. 25:67-78. 
Bunnell SC, Diehn M, Yaffe MB, Findell PR, Cantley LC, and Berg LJ. 2000. Biochemical interactions 
integrating Itk with the T cell receptor-initiated signaling cascade. J. Biol. Chem. 275:2219-2230.   
Cayota A, Vuillier F, Siciliano J, and Dighiero G. 1994. Defective protein tyrosine phosphorylation and altered 
levels of p59fyn and p56lck in CD4 T cells from HIV-1 infected patients. Int. Immunol. 6:611-621. 
Cefai D, Ferrer M, Serpente N, Idziorek T, Dautry-Varsat A, Debre P, and Bismuth G. 1992. Internalization of 
HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with 
impairment of T cell activation. J. Immunol. 149:285-294. 
Cenciarelli C, Hohman RJ, Atkinson TP, Gusovsky F, and Weissman AM. 1992. Evidence for GTP-binding 
protein involvement in the tyrosine phosphorylation of the T cell receptor zeta chain. J. Biol. Chem.
267:14527-14530. 
Cenciarelli C, Wilhelm KG Jr, Guo A, and Weissman AM. 1996. T cell antigen receptor ubiquitination is a 
consequence of receptor-mediated tyrosine kinase activation. J. Biol. Chem. 271:8709-8713. 
Chae WJ, Lee HK, Han JH, Kim SW, Bothwell AL, Morio T, and Lee SK. 2004. Qualitatively differential 
regulation of T cell activation and apoptosis by T cell receptor zeta chain ITAMs and their tyrosine residues. 
Int. Immunol. 16:1225-1236.  
43
Chan AC, Dalton M, Johnson R, Kong GH, Wang T, Thoma R, and Kurosaki T. 1995. Activation of ZAP-70 
kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. 
EMBO J. 14:2499-2508. 
Chan AC, Irving BA, Fraser JD, and Weiss A. 1991. The zeta chain is associated with a tyrosine kinase and 
upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. Proc.
Natl. Acad. Sci. U. S. A. 88:9166-9170.   
Chan B, Lanyi A, Song HK, Griesbach J, Simarro-Grande M, Poy F, Howie D, Sumegi J, Terhorst C, and Eck 
MJ. 2003. SAP couples Fyn to SLAM immune receptors. Nat. Cell. Biol. 5:155-160. 
Chau LA and Madrenas J. 1999. Phospho-LAT-independent activation of the ras-mitogen-activated protein 
kinase pathway: a differential recruitment model of TCR partial agonist signaling. J. Immunol. 163:1853-1858. 
Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, and Maniatis T. 1995. Signal-induced 
site-specific phosphorylation targets IțBĮ to the ubiquitin-proteasome pathway. Genes Dev. 9:1586– 1597 
Chiang GG, and Sefton BM. 2001. Specific dephosphorylation of the Lck tyrosine protein kinase at Tyr-394 
by the SHP-1 protein-tyrosine phosphatase. J. Biol. Chem. 276:23173-23178. 
Chiang YJ, Kole HK, Brown K, Naramura M, Fukuhara S, Hu RJ, Jang IK, Gutkind JS, Shevach E, and Gu H. 
2000. Cbl-b regulates the CD28 dependence of T-cell activation. Nature. 2000. 403:216-220. 
Ching KA, Grasis JA, Tailor P, Kawakami Y, Kawakami T, Tsoukas CD. 2000. TCR/CD3-Induced activation 
and binding of Emt/Itk to linker of activated T cell complexes: requirement for the Src homology 2 domain. J.
Immunol. 165:256-262. 
Chow LM, Fournel M, Davidson D, Veillette A. 1993. Negative regulation of T-cell receptor signalling by 
tyrosine protein kinase p50csk. Nature. 365:156-160.   
Chu DH, Spits H, Peyron JF, Rowley RB, Bolen JB, and Weiss A. The Syk protein tyrosine kinase can 
function independently of CD45 or Lck in T cell antigen receptor signaling. EMBO J. 15:6251-661.   
Clements JL, Yang B, Ross-Barta SE, Eliason SL, Hrstka RF, Williamson RA, and Koretzky GA. 1998. 
Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development. Science.
281:416-419.   
Cohen GB, Ren R, and Baltimore D. 1995. Modular binding domains in signal transduction proteins. Cell.
80:237-248. 
Collins TL, and Burakoff SJ. 1993. Tyrosine kinase activity of CD4-associated p56lck may not be required for 
CD4-dependent T-cell activation. Proc. Natl. Acad. Sci. U. S. A. 90:11885-1189. 
Cooke MP, Abraham KM, Forbush KA, and Perlmutter RM. 1991. Regulation of T cell  
receptor signaling by a src family protein-tyrosine kinase (p59fyn). Cell. 65:281-291. 
Cooke MP, Perlmutter RM. 1989. Expression of a novel form of the fyn proto-oncogene in hematopoietic 
cells. New Biol. 1:66-74. 
Cooper JA, and King CS. 1986. Dephosphorylation or antibody binding to the carboxy  
terminus stimulates pp60c-src. Mol. Cell. Biol. 6:4467-4477.   
Cooper JA, Gould KL, Cartwright CA, and Hunter T. 1986. Tyr527 is phosphorylated in pp60c-src: 
implications for regulation. Science. 231:1431-1434.   
Coudronniere N, Villalba M, Englund N, and Altman A. 2000. NF-kappa B activation induced by T cell 
receptor/CD28 costimulation is mediated by protein kinase C-theta. Proc. Natl. Acad. Sci. U. S. A. 97:3394-
3399.   
44
Courtneidge SA. 1985. Activation of the pp60c-src kinase by middle T antigen binding or by 
dephosphorylation. EMBO J. 4:1471-1477. 
Couture C, Baier G, Altman A, and Mustelin T. 1994. p56lck-independent activation and tyrosine 
phosphorylation of p72syk by T-cell antigen receptor/CD3 stimulation. Proc. Natl. Acad. Sci. U. S. A.
91:5301-5305. 
Couture C, Songyang Z, Jascur T, Williams S, Tailor P, Cantley LC, Mustelin T. 1996. Regulation of the Lck 
SH2 domain by tyrosine phosphorylation. J. Biol. Chem. 271:24880-24884. 
Criado G, Madrenas J. 2004. Superantigen stimulation reveals the contribution of Lck to negative regulation of 
T cell activation. J. Immunol. 172:222-230.   
da Silva AJ, Li Z, de Vera C, Canto E, Findell P, and Rudd CE. 1997. Cloning of a novel T-cell protein FYB 
that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production. 
Proc. Natl. Acad. Sci. U. S. A. 94:7493-7498. 
Davidson D, Bakinowski M, Thomas ML, Horejsi V, and Veillette A. 2003. Phosphorylation-dependent 
regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Mol. Cell. Biol.
23:2017-2028.  
Davidson D, Schraven B, and Veillette A. 2007. PAG-associated FynT regulates calcium signaling and 
promotes anergy in T lymphocytes. Mol. Cell. Biol. 27:1960-1973. 
Davidson D, Shi X, Zhang S, Wang H, Nemer M, Ono N, Ohno S, Yanagi Y, and Veillette A. 2004. Genetic 
evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 
cytokine regulation. Immunity. 21:707-717.  
Deckert M, Elly C, Altman A, and Liu YC. 1998. Coordinated regulation of the tyrosine phosphorylation of 
Cbl by Fyn and Syk tyrosine kinases. J. Biol. Chem. 273:8867-8874.   
Delespine-Carmagnat M, Bouvier G, Allee G, Fagard R, and Bertoglio J. 1999. Biochemical analysis of 
interleukin-2 receptor beta chain phosphorylation by p56(lck). FEBS Lett. 447:241-246. 
Denny MF, Kaufman HC, Chan AC, and Straus DB. 1999. The lck SH3 domain is required for activation of 
the mitogen-activated protein kinase pathway but not the initiation of T-cell antigen receptor signaling. J. Biol. 
Chem. 274:5146-5152. 
Denny MF, Patai B, and Straus DB. 2000. Differential T-cell antigen receptor signaling mediated by the Src 
family kinases Lck and Fyn. Mol. Cell. Biol. 20:1426-1435. 
Di Bartolo V, Mege D, Germain V, Pelosi M, Dufour E, Michel F, Magistrelli G, Isacchi A, and Acuto O. 
1999. Tyrosine 319, a newly identified phosphorylation site of ZAP-70, plays a critical role in T cell antigen 
receptor signaling. J. Biol. Chem. 274:6285-6294. 
Di Somma MM, Nuti S, Telford JL, and Baldari CT. 1995. p56lck plays a key role in transducing apoptotic 
signals in T cells. FEBS Lett. 363:101-104. 
Dobenecker MW, Schmedt C, Okada M, and Tarakhovsky A. 2005. The ubiquitously expressed Csk adaptor 
protein Cbp is dispensable for embryogenesis and T-cell development and function. Mol. Cell. Biol. 25:10533-
10542.  
Donovan JA, Wange RL, Langdon WY, and Samelson LE. 1994. The protein product of the c-cbl 
protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen 
receptor. J. Biol. Chem. 269:22921-22924.   
D'Oro U, Vacchio MS, Weissman AM, and Ashwell JD. 1997. Activation of the Lck tyrosine kinase targets 
cell surface T cell antigen receptors for lysosomal degradation. Immunity. 1997 7:619-628.   
45
Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA. 1990. Stimulation of p21ras upon T-cell 
activation. Nature. 346:719-723.   
Duan L, Miura Y, Dimri M, Majumder B, Dodge IL, Reddi AL, Ghosh A, Fernandes N, Zhou P, Mullane-
Robinson K, Rao N, Donoghue S, Rogers RA, Bowtell D, Naramura M, Gu H, Band V, and Band H. 2003. 
Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is 
dispensable for endocytosis. J. Biol. Chem. 278:28950-28960.  
Duplay P, Thome M, Herve F, and Acuto O. 1994. p56lck interacts via its src homology 2 domain with the 
ZAP-70 kinase. J. Exp. Med. 179:1163-1172. 
Dustin ML. 2005. A dynamic view of the immunological synapse. Semin. Immunol. 17:400-410. 
Ebinu JO, Stang SL, Teixeira C, Bottorff DA, Hooton J, Blumberg PM, Barry M, Bleakley RC, Ostergaard 
HL, and Stone JC. 2000. RasGRP links T-cell receptor signaling to Ras. Blood. 95:3199-3203.   
Ehrlich LI, Ebert PJ, Krummel MF, Weiss A, and Davis MM. 2002. Dynamics of p56lck translocation to the T 
cell immunological synapse following agonist and antagonist stimulation. Immunity. 17:809-822. 
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, and Tuschl T. 2001. Duplexes of 21 nucleotide 
RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494-498.   
Feshchenko EA, Langdon WY, Tsygankov AY. 1998. Fyn, Yes, and Syk phosphorylation sites in c-Cbl map 
to the same tyrosine residues that become phosphorylated in activated T cells. J. Biol. Chem. 273:8323-8331.  
Filby A, Seddon B, Kleczkowska J, Salmond R, Tomlinson P, Smida M, Lindquist JA, Schraven B, and 
Zamoyska R. 2007. Fyn Regulates the Duration of TCR Engagement Needed for Commitment to Effector 
Function. J. Immunol. 179:4635-4644. 
Filipp D, Leung BL, Zhang J, Veillette A, and Julius M. 2004. Enrichment of Lck in lipid rafts regulates 
colocalized Fyn activation and the initiation of proximal signals through TCR alpha beta. J. Immunol.
172:4266-4274. 
Filipp D, Zhang J, Leung BL, Shaw A, Levin SD, Veillette A, and Julius M. 2003. Regulation of Fyn through 
translocation of activated Lck into lipid rafts. J. Exp. Med. 197:1221-1227.   
Finco TS, Kadlecek T, Zhang W, Samelson LE, and Weiss A. 1998. LAT is required for  
TCR-mediated activation of PLCgamma1 and the Ras pathway. Immunity. 9:617-626.   
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, and Mello CC. 1998. Potent and specific genetic 
interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:806-811.   
Frank C, Burkhardt C, Imhof D, Ringel J, Zschornig O, Wieligmann K, Zacharias M, and  
Bohmer FD. 2004. Effective dephosphorylation of Src substrates by SHP-1. J Biol Chem. 279:11375-11383. 
Fukushima A, Hatanaka Y, Chang JW, Takamatsu M, Singh N, and Iwashima M. Lck couples Shc to TCR 
signaling. Cell. Signal. 18:1182-1189. 
Giglione C, Gonfloni S, and Parmeggiani A. 2001. Differential actions of p60c-Src and Lck kinases on the Ras 
regulators p120-GAP and GDP/GTP exchange factor CDC25Mm. Eur J Biochem. 268:3275-3283. 
Goldman FD, Ballas ZK, Schutte BC, Kemp J, Hollenback C, Noraz N, and Taylor N. 1998. Defective 
expression of p56lck in an infant with severe combined immunodeficiency. J. Clin. Invest. 102:421-429.   
Goldsmith MA, and Weiss A. 1987. Isolation and characterization of a T-lymphocyte somatic mutant with 
altered signal transduction by the antigen receptor. Proc. Natl. Acad. Sci. U. S. A. 84:6879-6883. 
Gorska MM, Stafford SJ, Cen O, Sur S, and Alam R. 2004. Unc119, a novel activator of Lck/Fyn, is essential 
for T cell activation. J. Exp. Med. 199:369-379. 
46
Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, and Dustin ML. 1999. The 
immunological synapse: a molecular machine controlling T cell activation. Science. 285:221-227.   
Greenway A, Azad A, Mills J, and McPhee D. 1996. Human immunodeficiency virus type 1 Nef binds directly 
to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J. Virol. 70:6701-6708. 
Groves T, Smiley P, Cooke MP, Forbush K, Perlmutter RM, and Guidos CJ. 1996. Fyn can partially substitute 
for Lck in T lymphocyte development. Immunity. 5:417-428.   
Gruber C, Henkel M, Budach W, Belka C, Jendrossek V. 2004. Involvement of tyrosine kinase p56/Lck in 
apoptosis induction by anticancer drugs. Biochem Pharmacol. 67:1859-1872.   
Gu C, Ma YC, Benjamin J, Littman D, Chao MV, and Huang XY. 2000. Apoptotic signaling through the beta 
-adrenergic receptor. A new Gs effector pathway. J. Biol. Chem. 275:20726-20733. 
Gulbins E, Coggeshall KM, Baier G, Katzav S, Burn P, and Altman A.1993. Tyrosine kinase-stimulated 
guanine nucleotide exchange activity of Vav in T cell activation. Science. 260:822-825.  
Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, and Connelly PA. 
1996. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and 
FynT-dependent T cell activation. J. Biol. Chem. 271:695-701.  
Harder T. 2001. Raft membrane domains and immunoreceptor functions. Adv. Immunol. 77:45. 
Hartley DA, Hurley TR, Hardwick JS, Lund TC, Medveczky PG, and Sefton BM. 1999. Activation of the lck 
tyrosine-protein kinase by the binding of the tip protein of herpesvirus saimiri in the absence of regulatory 
tyrosine phosphorylation. J. Biol. Chem. 274:20056-20059. 
Hatakeyama M, Kono T, Kobayashi N, Kawahara A, Levin SD, Perlmutter RM, and Taniguchi T. 1991. 
Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular 
association. Science. 252:1523-1528.   
Haughn L, Gratton S, Caron L, Sekaly RP, Veillette A, and Julius M. 1992. Association of tyrosine kinase 
p56lck with CD4 inhibits the induction of growth through the alpha beta T-cell receptor. Nature. 358:328-331.   
Hawash IY, Kesavan KP, Magee AI, Geahlen RL, and Harrison ML. 2002. The Lck SH3 domain negatively 
regulates localization to lipid rafts through an interaction with c-Cbl. J. Biol. Chem. 277:5683-5691. 
Heyeck SD, Wilcox HM, Bunnell SC, and Berg LJ. 1997. Lck phosphorylates the activation loop tyrosine of 
the Itk kinase domain and activates Itk kinase activity. J. Biol. Chem. 272:25401-25408.  
Holdorf AD, Green JM, Levin SD, Denny MF, Straus DB, Link V, Changelian PS, Allen PM, Shaw AS. 1999. 
Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J. 
Exp. Med. 190:375-384. 
Holsinger LJ, Graef IA, Swat W, Chi T, Bautista DM, Davidson L, Lewis RS, Alt FW, Crabtree GR. 1998. 
Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal 
transduction. Curr. Biol. 8:563-572. 
Horak ID, Gress RE, Lucas PJ, Horak EM, Waldmann TA, and Bolen JB. 1991. T-lymphocyte interleukin 2-
dependent tyrosine protein kinase signal transduction involves the activation of p56lck. Proc. Natl. Acad. Sci. 
U. S. A. 88:1996-2000. 
Horejsi V. 2003. The roles of membrane microdomains (rafts) in T cell activation. Immunol. Rev. 191:148 
Hou D, Cenciarelli C, Jensen JP, Nguygen HB, Weissman AM. 1994. Activation-dependent ubiquitination of a 
T cell antigen receptor subunit on multiple intracellular lysines. J. Biol. Chem. 269:14244-14247. 
Hunter S, Burton EA, Wu SC, and Anderson SM. 1999. Fyn associates with Cbl and phosphorylates tyrosine 
731 in Cbl, a binding site for phosphatidylinositol 3-kinase. J Biol Chem. 274:2097-2106. 
47
Hur EM, Son M, Lee OH, Choi YB, Park C, Lee H, and Yun Y. 2003. LIME, a novel transmembrane adaptor 
protein, associates with p56lck and mediates T cell activation. J. Exp. Med. 198:1463-1473. 
Hur YG, Yun Y, and Won J. 2004. Rosmarinic acid induces p56lck-dependent apoptosis in Jurkat and 
peripheral T cells via mitochondrial pathway independent from Fas/Fas ligand interaction. J. Immunol. 172:79-
87.  
Ilangumaran SH, He T, and Hoessli DC. 2000. Microdomains in lymphocyte signalling: beyond GPI-anchored 
proteins. Immunol. Today. 21:2 
Imamoto A, and Soriano P. 1993. Disruption of the csk gene, encoding a negative regulator of Src family 
tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell. 73:1117-1124. 
Inngjerdingen M, Torgersen KM, and Maghazachi AA. 2002. Lck is required for stromal cell-derived factor 1 
alpha (CXCL12)-induced lymphoid cell chemotaxis. Blood. 99:4318-4325. 
Irvin BJ, Williams BL, Nilson AE, Maynor HO, Abraham RT. 2000. Pleiotropic contributions of 
phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies 
of a PLC-gamma1-deficient Jurkat T-cell line. Mol. Cell. Biol. 20:9149-9161.   
Irving BA, Chan AC, and Weiss A. 1993. Functional characterization of a signal transducing motif present in 
the T cell antigen receptor   chain. J. Exp. Med. 177:1093-1103. 
Iwashima M, Irving BA, van Oers NS, Chan AC, and Weiss A. 1994. Sequential interactions of the TCR with 
two distinct cytoplasmic tyrosine kinases. Science. 263:1136-1139.  
Jain J, McCaffrey PG, Miner Z, Kerppola TK, Lambert JN, Verdine GL, Curran T, Rao A. 1993. The T-cell 
transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature. 365:352-355.   
Jiang Y, and Cheng H. 2007. Evidence of LAT as a dual substrate for Lck and Syk in T lymphocytes. Leuk. 
Res. 31:541-545. 
Johnson DR, Bhatnagar RS, Knoll LJ, and Gordon JI.1994. Genetic and biochemical studies of protein N-
myristoylation. Annu. Rev. Biochem. 63:869-914. 
Joung I, Kim T, Stolz LA, Payne G, Winkler DG, Walsh CT, Strominger JL, Shin J. 1995. Modification of 
Ser59 in the unique N-terminal region of tyrosine kinase p56lck regulates specificity of its Src homology 2 
domain. Proc. Natl. Acad. Sci. U. S. A. 92:5778-5782. 
Jury EC, Kabouridis PS, Abba A, Mageed RA, Isenberg DA. 2003. Increased ubiquitination and reduced 
expression of LCK in T lymphocytes from patients with systemic lupus erythematosus. Arthritis. Rheum.
48:1343-1354.   
Kanazawa S, Ilic D, Hashiyama M, Noumura T, Yamamoto T, Suda T, and Aizawa S. 1996. p59fyn-p125FAK 
cooperation in development of CD4+CD8+ thymocytes. Blood. 87:865-870.  
Karnitz L, Sutor SL, Torigoe T, Reed JC, Bell MP, McKean DJ, Leibson PJ, and Abraham RT. 1992. Effects 
of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-
cell line. Mol. Cell. Biol. 12:4521-4530. 
Kassenbrock CK, and Anderson SM. 2004. Regulation of ubiquitin protein ligase activity in c-Cbl by 
phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point 
mutations. J. Biol. Chem. 279:28017-28027.  
Kawabuchi M, Satomi Y, Takao T, Shimonishi Y, Nada S, Nagai K, Tarakhovsky A, Okada M. 2000. 
Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature. 404:999-
1003. 
Kersh EN, Kersh GJ, and Allen PM. 1999. Partially phosphorylated T cell receptor zeta molecules can inhibit 
T cell activation. J. Exp. Med. 190:1627-1636. 
48
Kersh EN, Shaw AS, and Allen PM. 1998a. Fidelity of T cell activation through multistep T cell receptor zeta 
phosphorylation. Science. 281:572-575.  
Kersh GJ, Kersh EN, Fremont DH, and Allen PM. 1998b. High- and low-potency ligands with similar 
affinities for the TCR: the importance of kinetics in TCR signaling. Immunity. 9:817-826.   
Kim PW, Sun ZY, Blacklow SC, Wagner G, and Eck MJ. 2003. A zinc clasp structure tethers Lck to T cell 
coreceptors CD4 and CD8. Science. 301:1725-1728.  
Kishihara K, Penninger J, Wallace VA, Kundig TM, Kawai K, Wakeham A, Timms E, Pfeffer K, Ohashi PS, 
and Thomas ML. 1993. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 
protein tyrosine phosphatase-deficient mice. Cell. 74:143-156. 
Kitamura N, Kitamura A, Toyoshima K, Hirayama Y, and Yoshida M. 1982. Avian sarcoma virus Y73 
genome sequence and structural similarity of its transforming gene product to that of Rous sarcoma virus. 
Nature. 297:205-208.  
Koegl M, Zlatkine P, Ley SC, Courtneidge SA, and Magee AI. 1994. Palmitoylation of multiple Src-family 
kinases at a homologous N-terminal motif. Biochem. J. 303:749-753. 
Kong G, Dalton M, Wardenburg JB, Straus D, Kurosaki T, and Chan AC. 1996. Distinct tyrosine 
phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function. Mol. 
Cell. Biol. 16:5026-5035. 
Konishi H, Yamauchi E, Taniguchi H, Yamamoto T, Matsuzaki H, Takemura Y, Ohmae K, Kikkawa U, and 
Nishizuka Y. 2001. Phosphorylation sites of protein kinase C delta in H2O2-treated cells and its activation by 
tyrosine kinase in vitro. Proc. Natl. Acad. Sci. U. S. A. 98:6587-6592. 
Kon-Kozlowski M, Pani G, Pawson T, and Siminovitch KA. 1996. The tyrosine phosphatase PTP1C 
associates with Vav, Grb2, and mSos1 in hematopoietic cells. J. Biol. Chem. 271:3856-3862. 
Koretzky GA, Picus J, Thomas ML, and Weiss A. 1990. Tyrosine phosphatase CD45 is essential for coupling 
T-cell antigen receptor to the phosphatidyl inositol pathway. Nature. 346:66-68.   
Kruisbeek AM, Haks MC, Carleton M, Michie AM, Zúñiga-Pflücker JC, and Wiest DL. 2000. Branching out 
to gain control: how the pre-TCR is linked to multiple functions. Immunol. Today. 21:637-644. 
Kuhns MS, Davis MM, and Garcia KC. 2006. Deconstructing the form and function of the TCR/CD3 
complex. Immunity. 24:133-139.   
Kumar A, Humphreys TD, Kremer KN, Bramati PS, Bradfield L, Edgar CE, and Hedin KE. 2006. CXCR4 
physically associates with the T cell receptor to signal in T cells. Immunity. 25:213-224. 
Labadia ME, Ingraham RH, Schembri-King J, Morelock MM, and Jakes S. 1996. Binding affinities of the SH2 
domains of ZAP-70, p56lck and Shc to the zeta chain ITAMs of the T-cell receptor determined by surface 
plasmon resonance. J. Leukoc. Biol. 59:740-746.  
Latour S, Roncagalli R, Chen R, Bakinowski M, Shi X, Schwartzberg PL, Davidson D, and Veillette A. 2003. 
Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in 
immune regulation. Nat. Cell. Biol. 5:149-154.   
Lee JE, Cossoy MB, Chau LA, Singh B, and Madrenas J. 1997. Inactivation of lck and loss of TCR-mediated 
signaling upon persistent engagement with complexes of peptide:MHC molecules. J. Immunol. 159:61-69. 
Lefkowitz RJ, Pierce KL, and Luttrell LM. 2002. Dancing with different partners: protein kinase a 
phosphorylation of seven membrane-spanning receptors regulates their G protein-coupling specificity. Mol.
Pharmacol. 62:971-974. 
49
Legname G, Seddon B, Lovatt M, Tomlinson P, Sarner N, Tolaini M, Williams K, Norton T, Kioussis D, and 
Zamoyska R. 2000. Inducible expression of a p56Lck transgene reveals a central role for Lck in the 
differentiation of CD4 SP thymocytes. Immunity. 12:537-546. 
Levin SD, Anderson SJ, Forbush KA, Perlmutter RM. 1993. A dominant-negative transgene defines a role for 
p56lck in thymopoiesis. EMBO J. 12:1671-1680. 
Lewis LA, Chung CD, Chen J, Parnes JR, Moran M, Patel VP, and Miceli MC. 1997. The Lck SH2 
phosphotyrosine binding site is critical for efficient TCR-induced processive tyrosine phosphorylation of the 
zeta-chain and IL-2 production.. J. Immunol. 159:2292-2300.  
Ley SC, Marsh M, Bebbington CR, Proudfoot K, and Jordan P. 1994.Distinct intracellular localization of Lck 
and Fyn protein tyrosine kinases in human T lymphocytes. J. Cell. Biol. 125:639-649. 
Liao F, Shin HS, and Rhee SG. 1993. In vitro tyrosine phosphorylation of PLC-gamma 1 and PLC-gamma 2 
by src-family protein tyrosine kinases. Biochem. Biophys. Res. Commun. 191:1028-1033. 
Liao XC, and Littman DR. 1995. Altered T cell receptor signaling and disrupted T cell development in mice 
lacking Itk. Immunity. 3:757-769.   
Lin J, and Weiss A, Finco TS. 1999. Localization of LAT in glycolipid-enriched microdomains is required for 
T cell activation. J. Biol. Chem. 274:28861-28864. 
Lin J, and Weiss A. 2001. Identification of the minimal tyrosine residues required for linker for activation of T 
cell function. J. Biol. Chem. 276:29588-29595. 
Lin K, Longo NS, Wang X, Hewitt JA, and Abraham KM. 2000. Lck domains differentially contribute to pre-
T cell receptor (TCR)- and TCR-alpha/beta-regulated developmental transitions. J. Exp. Med. 191:703-716. 
Lin X, O'Mahony A, Mu Y, Geleziunas R, Greene WC. 2000. Protein kinase C-theta participates in NF-
kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta. 
Mol. Cell. Biol. 20:2933-2940.   
Lippert E, Jacques Y, and Hermouet S. 2000. Positive regulation of human T cell activation by Gi2 proteins 
and interleukin-8. J. Leukoc. Biol. 67:742-748. 
Liu SK, Fang N, Koretzky GA, and McGlade CJ. 1999. The hematopoietic-specific adaptor protein gads 
functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors. Curr. Biol. 9:67-75. 
Liu XQ, and Pawson T. 1991. The epidermal growth factor receptor phosphorylates GTPase-activating protein 
(GAP) at Tyr-460, adjacent to the GAP SH2 domains. Mol. Cell. Biol. 11:2511-2516.   
Liu Y, Witte S, Liu YC, Doyle M, Elly C, Altman A. 2000. Regulation of protein kinase Ctheta function 
during T cell activation by Lck-mediated tyrosine phosphorylation. J. Biol. Chem. 275:3603-3609.   
Lorenz U, Ravichandran KS, Pei D, Walsh CT, Burakoff SJ, and Neel BG. 1994. Lck-dependent tyrosyl 
phosphorylation of the phosphotyrosine phosphatase SH-PTP1 in murine T cells. Mol. Cell. Biol. 14:1824-
1834. 
Lorenz U, Ravichandran KS, Pei D, Walsh CT, Burakoff SJ, and Neel BG. 1994. Lck-dependent tyrosyl 
phosphorylation of the phosphotyrosine phosphatase SH-PTP1 in murine T cells. Mol. Cell. Biol. 4:1824-1834.  
Lovatt M, Filby A, Parravicini V, Werlen G, Palmer E, and Zamoyska R. 2006. Lck regulates the threshold of 
activation in primary T cells, while both Lck and Fyn contribute to the magnitude of the extracellular signal-
related kinase response. Mol. Cell. Biol. 26:8655-8665. 
Luo K, and Sefton BM. 1992. Activated lck tyrosine protein kinase stimulates antigen-independent 
interleukin-2 production in T cells. Mol. Cell. Biol. 12:4724-4732.   
50
Luo KX, and Sefton BM. 1990. Cross-linking of T-cell surface molecules CD4 and CD8 stimulates 
phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site. Mol. Cell. Biol. 10:5305-
5313. 
Lupher ML, Reedquist KA, Miyake S, Langdon WY, and Band H. 1996. A novel phosphotyrosine-binding 
domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells. 
J. Biol. Chem. 271:24063-24068. 
Luton F, Legendre V, Gorvel JP, Schmitt-Verhulst AM, and Boyer C. 1997. Tyrosine and serine protein kinase 
activities associated with ligand-induced internalized TCR/CD3 complexes. J. Immunol. 158:3140-3147. 
Luttrell DK, and Luttrell LM. 2004. Not so strange bedfellows: G-protein-coupled receptors and Src family 
kinases. Oncogene. 23:7969-7978. 
Luttrell LM, Daaka Y, and Lefkowitz RJ. 1999. Regulation of tyrosine kinase cascades by G-protein-coupled 
receptors. Curr.Opin. Cell. Biol. 11:177-183. 
Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing TJ, and Lefkowitz RJ. 1996.  Role of c-Src 
tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-
activated protein kinases. J.Biol.Chem. 271:19443-19450. 
Luttrell LM, la Rocca GJ, van BT, Luttrell DK, and Lefkowitz RJ. 1997. Gbetagamma subunits mediate Src-
dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-
mediated Ras activation. J. Biol. Chem. 272:4637-4644. 
Ma YC, Huang J, Ali S, Lowry W, and Huang XY. 2000. Src tyrosine kinase is a novel direct effector of G 
proteins. Cell. 102:635-646. 
MacAuley A, Cooper JA. Structural differences between repressed and derepressed forms of p60c-src. Mol. 
Cell. Biol. 9:2648-2656. 
Madrenas J, Wange RL, Wang JL, Isakov N, Samelson LE, Germain RN. 1995. Zeta phosphorylation without 
ZAP-70 activation induced by TCR antagonists or partial agonists. Science. 267:515-518.   
Manninen A, Renkema GH, and Saksela K. 2000. Synergistic activation of NFAT by HIV-1 nef and the 
Ras/MAPK pathway. J. Biol. Chem. 275:16513-16517. 
Marchildon GA, Casnellie JE, Walsh KA, and Krebs EG. 1984. Covalently bound myristate in a lymphoma 
tyrosine protein kinase. Proc. Natl. Acad. Sci. U. S. A. 81:7679-7682. 
Marmor MD, and Julius M. 2001. Role for lipid rafts in regulating interleukin-2 receptor signaling. Blood.
98:1489. 
Marth JD, Cooper JA, King CS, Ziegler SF, Tinker DA, Overell RW, Krebs EG, and Perlmutter RM. 1988. 
Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck). Mol. 
Cell. Biol. 8:540-550. 
Marth JD, Peet R, Krebs EG, and Perlmutter RM. 1985. A lymphocyte-specific protein-tyrosine kinase gene is 
rearranged and overexpressed in the murine T cell lymphoma LSTRA. Cell. 43:393-404. 
Matache C, Onu A, Stefanescu M, Tanaseanu S, Dragomir C, Dolganiuc A, and Szegli G.  
2001. Dysregulation of p56lck kinase in patients with systemic lupus erythematosus. Autoimmunity. 34:27-38.   
Matache C, Stefanescu M, Onu A, Tanaseanu S, Matei I, Frade R, and Szegli G. 1999. p56lck activity and 
expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus. Autoimmunity.
29:111-120.   
Matsumoto R, Wang D, Blonska M, Li H, Kobayashi M, Pappu B, Chen Y, Wang D, and Lin X. 2005. 
Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation. 
Immunity. 23:575-585.   
51
May MJ, and Ghosh S. 1998. Signal transduction through NF-kappa B. Immunol Today. 19:80-88. 
McManus MT, Haines BB, Dillon CP, Whitehurst CE, van Parijs L, Chen J, and Sharp PA. 2002b. Small 
interfering RNA-mediated gene silencing in T lymphocytes. J. Immunol. 169: 5754-5760. 
McManus MT, Sharp PA. 2002a. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3: 
737-747. 
McNeill L, Salmond RJ, Cooper JC, Carret CK, Cassady-Cain RL, Roche-Molina M, Tandon P, Holmes N, 
and Alexander DR. 2007. The Differential Regulation of Lck Kinase Phosphorylation Sites by CD45 Is 
Critical for T Cell Receptor Signaling Responses. Immunity. 27:425-437. 
Miura-Shimura Y, Duan L, Rao NL, Reddi AL, Shimura H, Rottapel R, Druker BJ,  Tsygankov A, Band V, 
and Band H. 2003. Cbl-mediated Ubiquitinylation and Negative Regulation of Vav. J. Biol. Chem.
278:38495-38504. 
Molina TJ, Kishihara K, Siderovski DP, van Ewijk W, Narendran A, Timms E, Wakeham A, Paige CJ, 
Hartmann KU, Veillette A, Davidson D, and Mak TW. 1992. Profound block in thymocyte development in 
mice lacking p56lck. Nature. 357:161-164.   
Monks CR, Freiberg BA, Kupfer H, Sciaky N, and  Kupfer A. 1998. Three-dimensional segregation of 
supramolecular activation clusters in T cells. Nature. 395:82-86.  
Monks CR, Freiberg BA, Kupfer H, Sciaky N, and Kupfer A. 1998. Three-dimensional segregation of 
supramolecular activation clusters in T cells. Nature. 395:82-86.  
Monks CR, Kupfer H, Tamir I, Barlow A, and Kupfer A. 1997. Selective modulation of protein kinase C-theta 
during T-cell activation. Nature. 385:83-86. 
Murphy MA, Schnall RG, Venter DJ, Barnett L, Bertoncello I, Thien CBF, Langdon WY, and Bowtell DDL. 
1998. Tissue hyperplasia and enhanced T cell signalling via ZAP-70 in c-Cbl deficient mice. Mol. Cell. Biol.
18:4872–4882. 
Mustelin T, and Altman A. 1990. Dephosphorylation and activation of the T cell tyrosine kinase pp56lck by 
the leukocyte common antigen (CD45). Oncogene. 5:809-813.   
Mustelin T, Coggeshall KM, and Altman A. 1989. Rapid activation of the T-cell tyrosine protein kinase 
pp56lck by the CD45 phosphotyrosine phosphatase. Proc. Natl. Acad. Sci. U. S. A.. 86:6302-6306. 
Mustelin T, Pessa-Morikawa T, Autero M, Gassmann M, Andersson LC, Gahmberg CG, and Burn P. 1992. 
Regulation of the p59fyn protein tyrosine kinase by the CD45 phosphotyrosine phosphatase. Eur. J. Immunol.
22:1173-1178. 
Nada S, Okada M, MacAuley A, Cooper JA, Nakagawa H. 1991. Cloning of a complementary DNA for a 
protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature. 351:69-
72. 
Nada S, Yagi T, Takeda H, Tokunaga T, Nakagawa H, Ikawa Y, Okada M, and Aizawa S. 1993. Constitutive 
activation of Src family kinases in mouse embryos that lack Csk. Cell. 73:1125-1135.  
Napoli C, Lemieux C, and Jorgensen R. 1990. Introduction of a Chimeric Chalcone Synthase Gene into 
Petunia Results in Reversible Co-Suppression of Homologous Genes in trans. Plant Cell. 2:279-289.   
Naramura M, Jang IK, Kole H, Huang F, Haines D, Gu H. 2002. c-Cbl and Cbl-b regulate T cell 
responsiveness by promoting ligand-induced TCR down-modulation. Nat Immunol. 3:1192-1199. 
Naramura M, Kole HK, Hu R-J, and Gu H. 1998. Altered thymic positive selection and intracellular signals in 
Cbl-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 95:15547–15552. 
Nat Immunol. 1:322-328. 
52
Negishi I, Motoyama N, Nakayama K, Nakayama K, Senju S, Hatakeyama S, Zhang Q, Chan AC, and Loh 
DY. 1995. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature. 376:435-
438.   
Nel AE, Gupta S, Lee L, Ledbetter JA, Kanner SB. 1995. Ligation of the T-cell antigen receptor (TCR) 
induces association of hSos1, ZAP-70, phospholipase C-gamma 1, and other phosphoproteins with Grb2 and 
the zeta-chain of the TCR. J. Biol. Chem. 270:18428-18436.  
Nervi S, Atlan-Gepner C, Kahn-Perles B, Lecine P, Vialettes B, Imbert J, and Naquet P. 2000. Specific 
deficiency of p56lck expression in T lymphocytes from type 1 diabetic patients. J. Immunol. 165:5874-5883.  
Offermanns S. 2000. Mammalian G-protein function in vivo: new insights through altered gene expression. 
Rev .Physio.l Biochem.  Pharmacol. 140:63-133. 
Offermanns S. 2001. In vivo functions of heterotrimeric G-proteins: studies in Galpha-deficient mice. 
Oncogene. 20:1635-1642. 
Okada M and Nakagawa H. 1989. A protein tyrosine kinase involved in regulation of pp60c-src function. J.
Biol. Chem. 264:20886-20893.   
Okada M, Nada S, Yamanashi Y, Yamamoto T, and Nakagawa H. 1991. CSK: a protein-tyrosine kinase 
involved in regulation of src family kinases. J. Biol. Chem. 266:24249-24252.  
Olszowy MW, Leuchtmann PL, Veillette A, and Shaw AS. 1995. Comparison of p56lck and p59fyn protein 
expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines. J. Immunol. 155:4236-
4240. 
Osman N, Lucas SC, Turner H, and Cantrell D. 1995. A comparison of the interaction of Shc and the tyrosine 
kinase ZAP-70 with the T cell antigen receptor zeta chain tyrosine-based activation motif. J. Biol. Chem.
270:13981-13986.   
Ostergaard HL, Shackelford DA, Hurley TR, Johnson P, Hyman R, Sefton BM, and  Trowbridge IS.1989. 
Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-
cell lines. Proc. Natl. Acad. Sci. U. S. A. 86:8959-8963. 
Oyaizu N, Than S, McCloskey TW, and Pahwa S. 1995. Requirement of p56lck in T-cell receptor/CD3-
mediated apoptosis and Fas-ligand induction in Jurkat cells. Biochem Biophys Res Commun. 213:994-1001.   
Padrón D, Sato M, Shay JW, Gazdar AF, Minna JD, and Roth MG. 2007. Epidermal growth factor receptors 
with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-
regulation but are efficiently internalized. Cancer Res. 67:7695-7702. 
Paige LA, Nadler MJ, Harrison ML, Cassady JM, and Geahlen RL. 1993. Reversible palmitoylation of the 
protein-tyrosine kinase p56lck. J. Biol. Chem. 268:8669-8674.   
Pani G, Fischer KD, Mlinaric-Rascan I, Siminovitch KA. 1996. Signaling capacity of the T cell antigen 
receptor is negatively regulated by the PTP1C tyrosine phosphatase. J. Exp. Med. 184:839-852. 
Park S, and Jove R. 1993. Tyrosine phosphorylation of Ras GTPase-activating protein stabilizes its association 
with p62 at membranes of v-Src transformed cells. J. Biol. Chem. 268:25728-25734.   
Patrussi L, Ulivieri C, Lucherini OM, Paccani SR, Gamberucci A, Lanfrancone L, Pelicci PG, and Baldari CT. 
2007. p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells. Blood. 110:1730-1738.  
Pawson T. 1995. Protein modules and signalling networks. Nature. 373:573-580. 
Paz PE, Wang S, Clarke H, Lu X, Stokoe D, and Abo A. 2001. Mapping the Zap-70 phosphorylation sites on 
LAT (linker for activation of T cells) required for recruitment and activation of signalling proteins in T cells. 
Biochem. J. 356:461-471. 
53
Peacock JW, Jirik FR. 1999. TCR activation inhibits chemotaxis toward stromal cell-derived factor-1: 
evidence for reciprocal regulation between CXCR4 and the TCR. J. Immunol. 162:215-223. 
Pei D, Lorenz U, Klingmuller U, Neel BG, and Walsh CT. 1994. Intramolecular regulation of protein tyrosine 
phosphatase SH-PTP1: a new function for Src homology 2 domains. Biochemistry. 33:15483-15493. 
Pelosi M, Di Bartolo V, Mounier V, Mege D, Pascussi JM, Dufour E, Blondel A, and Acuto O. 1999. Tyrosine 
319 in the interdomain B of ZAP-70 is a binding site for the Src homology 2 domain of Lck. J. Biol. Chem. 
274:14229-14237. 
Peng SL, Gerth AJ, Ranger AM, and Glimcher LH. 2001. NFATc1 and NFATc2 together  
control both T and B cell activation and differentiation. Immunity. 14:13-20.  
Peter D, Jin SL, Conti M, Hatzelmann A, Zitt C. 2007. Differential expression and function of 
phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D. J.
Immunol. 178:4820-4831.   
Pingel JT, and Thomas ML. 1989. Evidence that the leukocyte-common antigen is required for antigen-
induced T lymphocyte proliferation. Cell. 58:1055-1065. 
Pitcher LA, and van Oers NS. 2003. T-cell receptor signal transmission: who gives an ITAM? Trends 
Immunol. 24:554-560. 
Pitcher LA, Young JA, Mathis MA, Wrage PC, Bartok B, and van Oers NS. 2003. The formation and 
functions of the 21- and 23-kDa tyrosine-phosphorylated TCR zeta subunits. Immunol Rev. 191:47-61. 
Pivniouk V, Tsitsikov E, Swinton P, Rathbun G, Alt FW, and Geha RS. 1998. Impaired viability and profound 
block in thymocyte development in mice lacking the adaptor protein SLP-76. Cell. 94:229-238. 
Plas DR, Johnson R, Pingel JT, Matthews RJ, Dalton M, Roy G, Chan AC, and Thomas ML. 1996. Direct 
regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science. 272:1173-1176. 
Priatel JJ, Teh SJ, Dower NA, Stone JC, and Teh HS. 2002. RasGRP1 transduces low-grade TCR signals 
which are critical for T cell development, homeostasis, and differentiation. Immunity. 17:617-627.  
Qian D, Lev S, van Oers NS, Dikic I, Schlessinger J, and Weiss A. 1997. Tyrosine phosphorylation of Pyk2 is 
selectively regulated by Fyn during TCR signaling. J. Exp. Med. 185:1253-1259.   
Racioppi L, Matarese G, D'Oro U, De Pascale M, Masci AM, Fontana S, and Zappacosta S. 1996. The role of 
CD4-Lck in T-cell receptor antagonism: evidence for negative signaling. Proc. Natl. Acad. Sci. U. S. A. 
93:10360-10365.   
Rao N, Miyake S, Reddi AL, Douillard P, Ghosh AK, Dodge IL, Zhou P, Fernandes ND, and Band H. 2002. 
Negative regulation of Lck by Cbl ubiquitin ligase. Proc. Natl. Acad. Sci. U. S. A. 99:3794-3799. 
Rapecki S, Allen R. 2002. Inhibition of human T cell activation by novel Src kinase inhibitors is dependent 
upon the complexity of the signal delivered to the cell. J. Pharmacol. Exp. Ther. 303:1325-1333.  
Ravichandran KS, Lee KK, Songyang Z, Cantley LC, Burn P, and Burakoff SJ. 1993. Interaction of Shc with 
the zeta chain of the T cell receptor upon T cell activation. 
Reth M. 1989. Antigen receptor tail clue. Nature.338:383-384.   
Romagnoli P, Strahan D, Pelosi M, Cantagrel A, and van Meerwijk JP. 2001. A potential role for protein 
tyrosine kinase p56(lck) in rheumatoid arthritis synovial fluid T lymphocyte hyporesponsiveness. Int. 
Immunol. 13:305-312.  
Roose JP, Mollenauer M, Gupta VA, Stone J, and Weiss A. 2005. A diacylglycerol-protein kinase C-RasGRP1 
pathway directs Ras activation upon antigen receptor stimulation of T cells. Mol. Cell. Biol. 25:4426-4441.   
54
Roose JP, Mollenauer M, Ho M, Kurosaki T, and Weiss A. 2007. Unusual interplay of two types of Ras 
activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes. Mol. Cell. Biol.
27:2732-2745.  
Rudd CE, Trevillyan JM, Dasgupta JD, Wong LL, and Schlossman, SF. 1988. The CD4 receptor is complexed 
in detergent lysates to a protein tyrosine kinase (pp58) from human T lymphocytes. Proc. Natl. Acad. Sci. 
U.S.A. 85:5190-5194 
Rudolph MG, Stanfield RL, and Wilson IA. 2006. How TCRs bind MHCs, peptides and coreceptors. Ann. 
Rev. Immunol. 24: 419-466. 
Salio M, Valitutti S, Lanzavecchia A. 1997. Agonist-induced T cell receptor down-regulation: molecular 
requirements and dissociation from T cell activation. Eur. J. Immunol. 27:1769-1773. 
Samelson LE, Phillips AF, Luong ET, and Klausner RD. 1990. Association of the fyn protein-tyrosine kinase 
with the T-cell antigen receptor. Proc. Natl. Acad. Sci. U. S. A. 87:4358-4362.   
Samraj AK, Stroh C, Fischer U, Schulze-Osthoff K. 2006. The tyrosine kinase Lck is a positive regulator of 
the mitochondrial apoptosis pathway by controlling Bak expression. Oncogene. 25:186-197. 
Sancho J, Peter ME, and Franco R. 1993. Coupling of GTP-binding to the T cell receptor (TCR) zeta-chain 
with TCR-mediated signal transduction. J.Immunol. 150:3230-3242. 
Sawabe T, Horiuchi T, Nakamura M, Tsukamoto H, Nakahara K, Harashima SI, Tsuchiya T, and Nakano S. 
2001. Defect of lck in a patient with common variable immunodeficiency. Int. J. Mol. Med. 7:609-614. 
Scherer DC, Brockman JA, Chen Z, Maniatis T, and Ballard DW. 1995. Signal-induced degradation of IțBĮ
requires site-specific ubiquitination. Proc. Natl. Acad. Sci. U. S. A. 92:259–263. 
Schrager JA, Der Minassian V, and Marsh JW. 2002. HIV Nef increases T cell ERK MAP kinase activity. J. 
Biol. Chem. 277:6137-6142. 
Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, and Ohashi PS. Selection of the T cell repertoire. 
Annu. Rev. Immunol. 17:829-874. 
Seddon B, and Zamoyska R. 2002. TCR signals mediated by Src family kinases are essential for the survival 
of naive T cells. J. Immunol. 169:2997-3005.  
Seddon B, Legname G, Tomlinson P, and Zamoyska R. 2000. Long-term survival but impaired homeostatic 
proliferation of Naïve T cells in the absence of p56lck. Science. 290:127-131. 
Sedwick CE, Morgan MM, Jusino L, Cannon JL, Miller J, Burkhardt JK. 1999. TCR, LFA-1, and CD28 play 
unique and complementary roles in signaling T cell cytoskeletal reorganization. J. Immunol. 162:1367-1375. 
Semba K, Nishizawa M, Miyajima N, Yoshida MC, Sukegawa J, Yamanashi Y, Sasaki M, Yamamoto T, and 
Toyoshima K. 1986. Yes-related protooncogene, syn, belongs to the protein-tyrosine kinase family. Proc. Natl. 
Acad. Sci. U. S. A. 83:5459-5463.  
Shan X, and Wange RL. 1999. Itk/Emt/Tsk activation in response to CD3 cross-linking in Jurkat T cells 
requires ZAP-70 and Lat and is independent of membrane recruitment. J. Biol. Chem. 274:29323-29330. 
Shan X, Balakir R, Criado G, Wood JS, Seminario MC, Madrenas J, Wange RL. 2001. Zap-70-independent 
Ca(2+) mobilization and Erk activation in Jurkat T cells in response to T-cell antigen receptor ligation. Mol.
Cell. Biol. 21:7137-7149.   
Shortman K and Wu L. 1996. Early T lymphocyte progenitors. Annu. Rev. Immunol. 14:29-47. 
Sicheri F, Moarefi I. and Kuriyan J. 1997. Crystal structure of the Src family tyrosine kinase Hck. Nature.
385:602-609.   
55
Sledz CA, Holko M, de Veer MJ, Silverman RH, and Williams BR. 2003. Activation of the interferon system 
by short-interfering RNAs. Nat. Cell. Biol. 5:834-849. 
Sloan-Lancaster J, Shaw AS, Rothbard JB, and Allen PM. 1994. Partial T cell signaling: altered phospho-zeta 
and lack of zap70 recruitment in APL-induced T cell anergy. Cell. 79:913-922. 
Smida M, Posevitz-Fejfar A, Horejsi V, Schraven B, and Lindquist JA. 2007. A novel negative regulatory 
function of the phosphoprotein associated with glycosphingolipid-enriched microdomains: blocking Ras 
activation. Blood. 110:596-615. 
Snapper SB, and Rosen FS. 1999. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and 
cytoskeletal organization. Annu. Rev. Immunol. 17:905. 
Sommer K, Guo B, Pomerantz JL, Bandaranayake AD, Moreno-Garcia ME, Ovechkina YL, and Rawlings DJ. 
2005. Phosphorylation of the CARMA1 linker controls NF-kappaB activation. Immunity. 23:561-574. 
Sommers CL, Dejarnette JB, Huang K, Lee J, El-Khoury D, Shores EW, and Love PE. 2000. Function of CD3 
epsilon-mediated signals in T cell development. J. Exp. Med. 192:913-919. 
Sommers CL, Menon RK, Grinberg A, Zhang W, Samelson LE, Love PE. 2001. Knock-in mutation of the 
distal four tyrosines of linker for activation of T cells blocks murine T cell development. J. Exp. Med.
194:135-142.  
Sozio MS, Mathis MA, Young JA, Walchli S, Pitcher LA, Wrage PC, Bartok B, Campbell A, Watts JD, 
Aebersold R, Van Huijsduijnen RH, and van Oers NS. 2004. PTPH1 is a predominant protein-tyrosine 
phosphatase capable of interacting with and dephosphorylating the T cell receptor zeta subunit. J. Biol. Chem.
279:7760-7769.  
Srinivasan M, and Frauwirth KA. 2007. Reciprocal NFAT1 and NFAT2 Nuclear Localization in CD8+ 
Anergic T Cells Is Regulated by Suboptimal Calcium Signaling. J. Immunol. 179:3734-3741.  
Stanners J, Kabouridis PS, McGuire KL, and Tsoukas CD. 1995. Interaction between G proteins and tyrosine 
kinases upon T cell receptor.CD3-mediated signaling. J. Biol. Chem. 270:30635-30642. 
Stefanova I, Hemmer B, Vergelli M, Martin R, Biddison WE, and Germain RN. 2003. TCR ligand 
discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat. Immunol.
4:248-254.   
Stein PL, Lee HM, Rich S, and Soriano P. 1992. pp59fyn mutant mice display differential signaling in 
thymocytes and peripheral T cells. Cell. 70:741-750. 
Stone JD, Conroy LA, Byth KF, Hederer RA, Howlett S, Takemoto Y, Holmes N, and Alexander DR. 1997. 
Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, 
TCR-zeta, and ZAP-70. J. Immunol. 158:5773-5782. 
Stowers L, Yelon D, Berg LJ, Chant J. 1995. Regulation of the polarization of T cells toward antigen-
presenting cells by Ras-related GTPase CDC42. Proc. Natl. Acad. Sci. U. S. A. 92:5027. 
Straus DB, Chan AC, Patai B, and Weiss A. 1996. SH2 domain function is essential for the role of the Lck 
tyrosine kinase in T cell receptor signal transduction. J. Biol. Chem. 271:9976-9981.  
Straus DB, Weiss A. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal 
transduction through the T cell antigen receptor. Cell. 70:585-593. 
Su B. and Karin M. 1996. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. 
Opin. Immunol. 8: 402-411. 
Sun Z, Arendt CW, Ellmeier W, Schaeffer EM, Sunshine MJ, Gandhi L, Annes J, Petrzilka D, Kupfer A, 
Schwartzberg PL, and Littman DR. 2000. PKC-theta is required for TCR-induced NF-kappa-B activation in 
mature but not immature T lymphocytes. Nature. 404: 402-407. 
56
Swaminathan G, and Tsygankov AY. 2006. The Cbl family proteins: ring leaders in regulation of cell 
signaling. J. Cell. Physiol. 209:21-43. 
Tavano R, Gri G, Molon B, Marinari B, Rudd CE, Tuosto L, Viola A. 2004. CD28 and lipid rafts coordinate 
recruitment of Lck to the immunological synapse of human T lymphocytes. J. Immunol. 173:5392-5397. 
Tewari K, Walent J, Svaren J, Zamoyska R, Suresh M. 2006. Differential requirement for Lck during primary 
and memory CD8+ T cell responses. Proc. Natl. Acad. Sci. U. S. A. 103:16388-16393. 
Thien CB, and Langdon WY. 2005. c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative 
regulation of signalling responses. Biochem. J.15:153-166.    
Thien CB, Bowtell DD, and Langdon WY. 1998. Perturbed regulation of ZAP-70 and sustained tyrosine 
phosphorylation of LAT and SLP-76 in c-Cbl-deficient thymocytes J. Immunol. 162:7133-7139. 
Thomas JE, Soriano P, and Brugge JS. 1991. Phosphorylation of c-Src on tyrosine 527 by another protein 
tyrosine kinase. Science. 254:568-571. 
Timson Gauen LK, Kong AN, Samelson LE, and Shaw AS. 1992. p59fyn tyrosine kinase associates with 
multiple T-cell receptor subunits through its unique amino-terminal domain. Mol.Cell. Biol. 12:5438-5446. 
Torgersen KM, Vang T, Abrahamsen H, Yaqub S, Horejsí V, Schraven B, Rolstad B, Mustelin T, Taskén K. 
2001. Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src 
kinase (Csk) from lipid rafts. J. Biol. Chem. 276:29313-29318. 
Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, and Baeuerle PA. 1995. Phosphorylation of human 
IțBĮ on serines 32 and 36 controls IțBĮ proteolysis and NF-țB activation in response to diverse stimuli. 
EMBO J. 14:2876-2883. 
Trobridge PA, and Levin SD. 2001. Lck plays a critical role in Ca(2+) mobilization and CD28 costimulation in 
mature primary T cells. Eur. J. Immunol. 31:3567-3579. 
Tsoukas CD, Stanners J, and Ching KA. 2000. Activation of heterotrimeric GTP-binding proteins upon 
TCR/CD3 engagement. Methods Mol.Biol. 134:319-324. 
Tsygankov AY, Broker BM, Fargnoli J, Ledbetter JA, Bolen JB. 1992. Activation of tyrosine kinase p60fyn 
following T cell antigen receptor cross-linking. J. Biol. Chem. 267:18259-18262. 
Tsygankov AY, Mahajan S, Fincke JE, and Bolen JB. 1996. Specific association of tyrosine-phosphorylated c-
Cbl with Fyn tyrosine kinase in T cells. J. Biol. Chem. 271:27130-27137. 
Turner JM, Brodsky MH, Irving BA, Levin SD, Perlmutter, RM, and Littman DR. 1990. Interaction of the 
unique N-terminal region of tyrosine kinase p561ck with cytoplasmic domains of CD4 and CD8 mediated by 
cysteine motifs. Cell. 60:755-765 
Utting O, Teh SJ, and Teh HS. 1998. T cells expressing receptors of different affinity for antigen ligands 
reveal a unique role for p59fyn in T cell development and optimal stimulation of T cells by antigen. J. 
Immunol. 160:5410-5419. 
Valitutti S, Muller S, Salio M, and Lanzavecchia A. 1997. Degradation of T cell receptor (TCR)-CD3-zeta 
complexes after antigenic stimulation. J. Exp. Med. 185:1859-1864.   
van Oers NS, Killeen N, and Weiss A. 1994. ZAP-70 is constitutively associated with tyrosine-phosphorylated 
TCR zeta in murine thymocytes and lymph node T cells. Immunity. 1:675-685.   
van Oers NS, Killeen N, and Weiss A. 1996b. Lck regulates the tyrosine phosphorylation of the T cell receptor 
subunits and ZAP-70 in murine thymocytes. J. Exp. Med. 183:1053-1062. 
van Oers NS, Love PE, Shores EW, and Weiss A. 1998. Regulation of TCR signal transduction in murine 
thymocytes by multiple TCR zeta-chain signaling motifs. J. Immunol. 160:163-170. 
57
van Oers NS, Lowin-Kropf B, Finlay D, Connolly K, and Weiss A. 1996a. Alpha beta T cell development is 
abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity. 5:429-436. 
van Oers NS, Tao W, Watts JD, Johnson P, Aebersold R, and Teh HS. 1993. Constitutive tyrosine 
phosphorylation of the T-cell receptor (TCR) zeta subunit: regulation of TCR-associated protein tyrosine 
kinase activity by TCR zeta. Mol. Cell. Biol. 13:5771-5780.  
van Oers NS, Tohlen B, Malissen B, Moomaw CR, Afendis S, and Slaughter CA. 2000. The 21- and 23-kD 
forms of TCR zeta are generated by specific ITAM phosphorylations. 
Veillette A, Bolen JB, and Bookman MA. 1989b Alterations in tyrosine protein phosphorylation induced by 
antibody-mediated cross-linking of the CD4 receptor of T lymphocytes. Mol. Cell. Biol. 9:4441-4446.  
Veillette A, BookmanM A, Horak EM, and Bolen JB. 1988. The CD4 and CD8 T cell surface antigens are 
associated with the internal membrane tyrosine-protein kinase p561ck. Cell. 55:301-308 
Veillette A, BookmanM A,H orak EM, SamelsonL E, Bolen, JB. 1989a. Signal transduction through the CD4 
receptor involves the activation of the internal membrane tyrosine-protein kinase p561ck. Nature. 338:257-259 
Veillette A, Zuniga-Pflucker JC, Bolen JB, and Kruisbeek AM. 1989c. Engagement of CD4 and CD8 
expressed on immature thymocytes induces activation of intracellular tyrosine phosphorylation pathways. J.
Exp. Med. 170:1671-1680.  
Voronova AF, and Sefton BM. 1986. Expression of a new tyrosine protein kinase is stimulated by retrovirus 
promoter insertion. Nature.319:682-685.   
Walk SF, March ME, and Ravichandran KS. 1998. Roles of Lck, Syk and ZAP-70 tyrosine kinases in TCR-
mediated phosphorylation of the adapter protein Shc. Eur. J. Immunol. 28:2265-2275.  
Wang HY, Altman Y, Fang D, Elly C, Dai Y, Shao Y, Liu YC. 2001. Cbl promotes ubiquitination of the T cell 
receptor zeta through an adaptor function of Zap-70. J. Biol. Chem. 276:26004-26011.  
Wange RL, Kong AN, and Samelson LE. 1992. A tyrosine-phosphorylated 70-kDa protein binds a 
photoaffinity analogue of ATP and associates with both the zeta chain and CD3 components of the activated T 
cell antigen receptor. J. Biol. Chem. 267:11685-11688.  
Wange RL, Malek SN, Desiderio S, and Samelson LE. 1993. Tandem SH2 domains of ZAP-70 bind to T cell 
antigen receptor zeta and CD3 epsilon from activated Jurkat T cells. J. Biol. Chem. 268:19797-197801.   
Wardenburg JB, Fu C, Jackman JK, Flotow H, Wilkinson SE, Williams DH, Johnson R, Kong G, Chan AC, 
and Findell PR. 1996. Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell 
receptor function. J. Biol. Chem. 271:19641-19644. 
Weber JR, Orstavik S, Torgersen KM, Danbolt NC, Berg SF, Ryan JC, Taskén K, Imboden JB, Vaage JT. 
1998. Molecular cloning of the cDNA encoding pp36, a tyrosine-phosphorylated adaptor protein selectively 
expressed by T cells and natural killer cells. J. Exp. Med. 187:1157-1161. 
Wegener AM, Letourneur F, Hoeveler A, Brocker T, Luton F, and Malissen B. 1992. The T cell receptor/CD3 
complex is composed of at least two autonomous transduction modules. Cell. 68:83-95. 
Wehner LE, Schroder N, Kamino K, Friedrich U, Biesinger B, Ruther U. 2001. Herpesvirus saimiri Tip gene 
causes T-cell lymphomas in transgenic mice. DNA Cell. Biol. 20:81-88.   
Weiss A, and Stobo JD. 1984. Requirement for the coexpression of T3 and the T cell antigen receptor on a 
malignant human T cell line. J. Exp. Med. 160:1284-1299. 
Wiese N, Tsygankov AY, Klauenberg U, Bolen JB, Fleischer B, and Bröker BM. 1996. Selective activation of 
T cell kinase p56lck by Herpesvirus saimiri protein tip. J. Biol. Chem. 271:847-852. 
58
Williams BL, Irvin BJ, Sutor SL, Chini CC, Yacyshyn E, Bubeck Wardenburg J, Dalton M, Chan AC, and 
Abraham RT. 1999. Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent 
phospholipase C-gamma1 and Ras activation. EMBO J. 18:1832-1844.  
Williams BL, Schreiber KL, Zhang W, Wange RL, Samelson LE, Leibson PJ, and Abraham RT. 1998. 
Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor: reconstitution studies in 
a ZAP-70-deficient Jurkat T-cell line. Mol. Cell. Biol. 18:1388-1399. 
Winkler DG, Park I, Kim T, Payne NS, Walsh CT, Strominger JL, and Shin J. 1993. Phosphorylation of Ser-
42 and Ser-59 in the N-terminal region of the tyrosine kinase p56lck. Proc. Natl. Acad. Sci. U. S. A. 90:5176-
5180. 
Wu J, Katrekar A, Honigberg LA, Smith AM, Conn MT, Tang J, Jeffery D, Mortara K, Sampang J, Williams 
SR, Buggy J, and Clark JM. 2006. Identification of substrates of human protein-tyrosine phosphatase PTPN22. 
J. Biol. Chem. 281:11002-11010.  
Xu H, and Littman DR. 1993. A kinase-independent function of Lck in potentiating antigen-specific T cell 
activation. Cell. 74:633-643.  
Xu S, Huo J, Tan JE, and Lam KP. 2005. Cbp deficiency alters Csk localization in lipid rafts but does not 
affect T-cell development. Mol. Cell. Biol. 25:8486-8495. 
Xu W, Doshi A, Lei M, Eck MJ, and Harrison SC. 1999. Crystal structures of c-Src reveal features of its 
autoinhibitory mechanism. Mol. Cell. 3:629-38. 
Xu W, Harrison SC, Eck MJ. 1997. Three-dimensional structure of the tyrosine kinase c-Src. Nature. 385:595-
602.  
Yablonski D, Kuhne MR, Kadlecek T, and Weiss A. 1998. Uncoupling of nonreceptor tyrosine kinases from 
PLC-gamma1 in an SLP-76-deficient T cell. Science. 281:413-416.   
Yamada H, Kong YY, Kishihara K, Mak TW, and Nomoto K. 1997. p56lck is not essential for the T-cell 
response to allo-MHC antigens. Immunology. 92:33-38.   
Yamaguchi H, and Hendrickson WA. 1996. Structural basis for activation of human lymphocyte kinase Lck 
upon tyrosine phosphorylation. Nature. 384:484-489. 
Yamasaki S, Tachibana M, Shinohara N, and Iwashima M. 1997. Lck-independent triggering of T-cell antigen 
receptor signal transduction by staphylococcal enterotoxins. J. Biol. Chem. 272:14787-14791.   
Yasuda K, Nagafuku M, Shima T, Okada M, Yagi T, Yamada T, Minaki Y, Kato A, Tani-Ichi S, Hamaoka T, 
and Kosugi A. 2002. Cutting edge: Fyn is essential for tyrosine phosphorylation of Csk-binding 
protein/phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells. J.
Immunol. 169:2813-2817. 
Yokouchi M, Kondo T, Sanjay A, Houghton A, Yoshimura A, Komiya S, Zhang H, and Baron R. 2001. Src-
catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J. Biol. Chem. 
276: 35185-35193. 
Yousefi S, Ma XZ, Singla R, Zhou YC, Sakac D, Bali M, Liu Y, Sahai BM, and Branch DR. 2003. HIV-1 
infection is facilitated in T cells by decreasing p56lck protein tyrosine kinase activity. Clin. Exp. Immunol.
133:78-90. 
Yu XZ, Levin SD, Madrenas J, and Anasetti C. 2004. Lck is required for activation-induced T cell death after 
TCR ligation with partial agonists. J. Immunol. 172:1437-1443.   
Yurchak LK, Sefton BM. 1995. Palmitoylation of either Cys-3 or Cys-5 is required for the biological activity 
of the Lck tyrosine protein kinase. Mol. Cell. Biol. 15:6914-6922. 
59
60
Zamoyska R, Basson A, Filby A, Legname G, Lovatt M, and Seddon B. 2003. The influence of the src-family 
kinases, Lck and Fyn, on T cell differentiation, survival and activation. Immunol. Rev. 191:107-118. 
Zenner G, Vorherr T, Mustelin T, and Burn P. 1996. Differential and multiple binding of signal transducing 
molecules to the ITAMs of the TCR-zeta chain. J. Cell. Biochem. 63:94-103.  
Zhang J, Somani AK, and Siminovitch KA. 2000. Roles of the SHP-1 tyrosine phosphatase in the negative 
regulation of cell signalling. Semin. Immunol. 12:361-378. 
Zhang L, Nabel GJ. 1994. Positive and negative regulation of IL-2 gene expression: role of multiple regulatory 
sites. Cytokine. 6:221-228. 
Zhang W, Irvin BJ, Trible RP, Abraham RT, and Samelson LE. 1999a. Functional analysis of LAT in TCR-
mediated signaling pathways using a LAT-deficient Jurkat cell line. Int. Immunol. 11:943-950.   
Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, and Samelson LE. 1998. LAT: the ZAP-70 tyrosine kinase 
substrate that links T cell receptor to cellular activation. Cell. 92:83-92.  
Zhang W, Sommers CL, Burshtyn DN, Stebbins CC, DeJarnette JB, Trible RP, Grinberg A, Tsay HC, Jacobs 
HM, Kessler CM, Long EO, Love PE, and Samelson LE. 1999b. Essential role of LAT in T cell development. 
Immunity. 10:323-332. 
Zhang W, Trible RP, Zhu M, Liu SK, McGlade CJ, and Samelson LE. 2000. Association of Grb2, Gads, and 
phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T 
cell angigen receptor-mediated signaling. J. Biol. Chem. 275:23355-23361. 
Zhang W, Trible RP, Zhu M, Liu SK, McGlade CJ, and Samelson LE. 2000. Association of Grb2, Gads, and 
phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T 
cell angigen receptor-mediated signaling. J. Biol. Chem. 275:23355-23361.   
Zhong W, Yamagata HD, Taguchi K, Akatsu H, Kamino K, Yamamoto T, Kosaka K, Takeda M, Kondo I, and 
Miki T. 2005. Lymphocyte-specific protein tyrosine kinase is a novel risk gene for Alzheimer disease. J. 
Neurol. Sci. 238:53-57.  
Zhou J, Stanners J, Kabouridis P, Han H, and Tsoukas CD. 1998. Inhibition of TCR/CD3-mediated signaling 
by a mutant of the hematopoietically expressed G16 GTP-binding protein. Eur.J Immunol. 28:1645-1655. 
